# EDGAR Filing Document

**Accession Number:** 0001601712
**File Stem:** 0001601712-25-000231
**Filing Date:** 2025-7
**Character Count:** 235469
**Document Hash:** 91a22c7828460de67f2c6601e5dd2fd3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001601712-25-000231.hdr.sgml**: 20250723

**ACCESSION NUMBER**: 0001601712-25-000231

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 89

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250723

**DATE AS OF CHANGE**: 20250723

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Synchrony Financial
- **CENTRAL INDEX KEY:** 0001601712
- **STANDARD INDUSTRIAL CLASSIFICATION:** FINANCE SERVICES [6199]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 510483352
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36560
- **FILM NUMBER:** 251143240

**BUSINESS ADDRESS:**
- **STREET 1:** 777 LONG RIDGE ROAD
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06902-1250
- **BUSINESS PHONE:** 203 585-2400

**MAIL ADDRESS:**
- **STREET 1:** 777 LONG RIDGE ROAD
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06902-1250

?xml version='1.0' encoding='ASCII'? syf-20250630

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q** 

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended June 30, 2025** 

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**

**001-36560** 

**(Commission File Number)**

![synchronylogorgbpositivea02.jpg](syf-20250630_g1.jpg)

**SYNCHRONY FINANCIAL** 

**(Exact name of registrant as specified in its charter)** 

---

| | |
|:---|:---|
| **Delaware** | **51-0483352** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(I.R.S. Employer<br>Identification No.)** |

---

---

| | | |
|:---|:---|:---|
| **777 Long Ridge Road** | **777 Long Ridge Road** | |
| **Stamford,** | **Connecticut** | **06902** |
| **(Address of principal executive offices)** | **(Address of principal executive offices)** | **(Zip Code)** |

---

**(Registrant's telephone number, including area code)** - **(203) 585-2400** 

**Securities Registered Pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **Common stock, par value $0.001 per share** | **SYF** | **New York Stock Exchange** |
| **Depositary Shares Each Representing a 1/40th Interest in a Share of 5.625% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A** | **SYFPrA** | **New York Stock Exchange** |
| **Depositary Shares Each Representing a 1/40th Interest in a Share of 8.250% Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B** | **SYFPrB** | **New York Stock Exchange** |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

------

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large Accelerated Filer | ☒ | Accelerated Filer | ☐ |
| Non-Accelerated Filer | ☐ | Smaller Reporting Company | ☐ |
| | | Emerging Growth Company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

The number of shares of the registrant's common stock, par value $0.001 per share, outstanding as of July 18, 2025 was 372,057,548.

------

**Synchrony Financial** 

---

| | |
|:---|:---|
| PART I - FINANCIAL INFORMATION | **Page** |
| <u>[Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](#i65ebfc98b75047a8b975220340389e60_13)</u> | <u>[6](#i65ebfc98b75047a8b975220340389e60_13)</u> |
| Item 1. Financial Statements: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Index to Condensed Consolidated Financial Statements](#i65ebfc98b75047a8b975220340389e60_64)</u> | <u>[35](#i65ebfc98b75047a8b975220340389e60_64)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Earnings –](#i65ebfc98b75047a8b975220340389e60_67)</u><br><u>[Three and six months ended June 30, 2025 and 2024](#i65ebfc98b75047a8b975220340389e60_67)</u> | <u>[36](#i65ebfc98b75047a8b975220340389e60_67)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Comprehensive Income –](#i65ebfc98b75047a8b975220340389e60_70)</u><br><u>[Three and six months ended June 30, 2025 and 2024](#i65ebfc98b75047a8b975220340389e60_70)</u> | <u>[37](#i65ebfc98b75047a8b975220340389e60_70)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Financial Position –](#i65ebfc98b75047a8b975220340389e60_73)</u><br><u>[June 30, 2025 and December 31, 2024](#i65ebfc98b75047a8b975220340389e60_73)</u> | <u>[38](#i65ebfc98b75047a8b975220340389e60_73)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Changes in Equity –](#i65ebfc98b75047a8b975220340389e60_76)</u><br><u>[Three and six months ended June 30, 2025 and 2024](#i65ebfc98b75047a8b975220340389e60_76)</u> | <u>[39](#i65ebfc98b75047a8b975220340389e60_76)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Cash Flows –](#i65ebfc98b75047a8b975220340389e60_79)</u><br><u>[Six months ended June 30, 2025 and 2024](#i65ebfc98b75047a8b975220340389e60_79)</u> | <u>[41](#i65ebfc98b75047a8b975220340389e60_79)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Notes to Condensed Consolidated Financial Statements](#i65ebfc98b75047a8b975220340389e60_82)</u> | <u>[42](#i65ebfc98b75047a8b975220340389e60_82)</u> |
| <u>[Item 3. Quantitative and Qualitative Disclosures About Market Risk](#i65ebfc98b75047a8b975220340389e60_157)</u> | <u>[65](#i65ebfc98b75047a8b975220340389e60_157)</u> |
| <u>[Item 4. Controls and Procedures](#i65ebfc98b75047a8b975220340389e60_160)</u> | <u>[65](#i65ebfc98b75047a8b975220340389e60_160)</u> |
| PART II - OTHER INFORMATION |  |
| <u>[Item 1. Legal Proceedings](#i65ebfc98b75047a8b975220340389e60_166)</u> | <u>[66](#i65ebfc98b75047a8b975220340389e60_166)</u> |
| <u>[Item 1A. Risk Factors](#i65ebfc98b75047a8b975220340389e60_169)</u> | <u>[66](#i65ebfc98b75047a8b975220340389e60_169)</u> |
| <u>[Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#i65ebfc98b75047a8b975220340389e60_172)</u> | <u>[66](#i65ebfc98b75047a8b975220340389e60_172)</u> |
| <u>[Item 3. Defaults Upon Senior Securities](#i65ebfc98b75047a8b975220340389e60_175)</u> | <u>[66](#i65ebfc98b75047a8b975220340389e60_175)</u> |
| <u>[Item 4. Mine Safety Disclosures](#i65ebfc98b75047a8b975220340389e60_178)</u> | <u>[66](#i65ebfc98b75047a8b975220340389e60_178)</u> |
| <u>[Item 5. Other Information](#i65ebfc98b75047a8b975220340389e60_181)</u> | <u>[66](#i65ebfc98b75047a8b975220340389e60_181)</u> |
| <u>Item 6. Exhibits</u> | <u>[68](#i65ebfc98b75047a8b975220340389e60_187)</u> |
| <u>[Signatures](#i65ebfc98b75047a8b975220340389e60_190)</u> | <u>[69](#i65ebfc98b75047a8b975220340389e60_190)</u> |

---

------

**Certain Defined Terms**

Except as the context may otherwise require in this report, references to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "we," "us," "our" and the "Company" are to SYNCHRONY FINANCIAL and its subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Synchrony" are to SYNCHRONY FINANCIAL only;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the "Bank" are to Synchrony Bank (a subsidiary of Synchrony);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the "Board of Directors" or "Board" are to Synchrony's board of directors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "CECL" are to the impairment model known as the Current Expected Credit Loss model, which is based on expected credit losses; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "VantageScore" are to a credit score developed by the three major credit reporting agencies which is used as a means of evaluating the likelihood that credit users will pay their obligations.

We provide a range of credit products through programs we have established with a diverse group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations and healthcare service providers, which, in our business and in this report, we refer to as our "partners." The terms of the programs all require cooperative efforts between us and our partners of varying natures and degrees to establish and operate the programs. Our use of the term "partners" to refer to these entities is not intended to, and does not, describe our legal relationship with them, imply that a legal partnership or other relationship exists between the parties or create any legal partnership or other relationship.

Unless otherwise indicated, references to "loan receivables" do not include loan receivables held for sale.

For a description of certain other terms we use, including "active account" and "purchase volume," see the notes to "*Management's Discussion and Analysis*—*Results of Operations*—*Other Financial and Statistical Data*" in our Annual Report on Form 10-K for the year ended December 31, 2024 (our "2024 Form 10-K"). There is no standard industry definition for many of these terms, and other companies may define them differently than we do.

"Synchrony" and its logos and other trademarks referred to in this report, including CareCredit®, Quickscreen®, Dual Card™, Synchrony Car Care™ and SyPI™, belong to us. Solely for convenience, we refer to our trademarks in this report without the™ and® symbols, but such references are not intended to indicate that we will not assert, to the fullest extent under applicable law, our rights to our trademarks. Other service marks, trademarks and trade names referred to in this report are the property of their respective owners.

On our website at https://investors.synchrony.com, we make available under the "Filings & Regulatory-SEC Filings" menu selection, free of charge, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to these reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") as soon as reasonably practicable after such reports or amendments are electronically filed with, or furnished to, the SEC. The SEC maintains an Internet site at www.sec.gov that contains reports, proxy and information statements, and other information that we file electronically with the SEC.

------

**Cautionary Note Regarding Forward-Looking Statements:**

Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, actual results could differ materially from those indicated in these forward-looking statements. Factors that could cause actual results to differ materially include global political, economic, business, competitive, market, regulatory and other factors and risks, such as: the impact of macroeconomic conditions, including factors impacting consumer confidence and economic growth in the United States, such as inflation, interest rates, tariffs (including retaliatory tariffs) and an economic downturn or recession, and whether industry trends we have identified develop as anticipated; the impact of changes in the U.S. presidential administration and Congress on fiscal, monetary and regulatory policy; retaining existing partners and attracting new partners, concentration of our revenue in a small number of partners, and promotion and support of our products by our partners; cyber-attacks or other security incidents or breaches; disruptions in the operations of our and our outsourced partners' computer systems and data centers; the financial performance of our partners; product, pricing and policy changes related to the Consumer Financial Protection Bureau's (the "CFPB") final rule on credit card late fees, which was vacated in April 2025; the sufficiency of our allowance for credit losses and the accuracy of the assumptions or estimates used in preparing our financial statements, including those related to the CECL accounting guidance; higher borrowing costs and adverse financial market conditions impacting our funding and liquidity, and any reduction in our credit ratings; our ability to grow our deposits in the future; damage to our reputation; our ability to securitize our loan receivables, occurrence of an early amortization of our securitization facilities, loss of the right to service or subservice our securitized loan receivables, and lower payment rates on our securitized loan receivables; changes in market interest rates; effectiveness of our risk management processes and procedures, reliance on models which may be inaccurate or misinterpreted, and our ability to manage our credit risk; our ability to offset increases in our costs in retailer share arrangements; competition in the consumer finance industry; our concentration in the U.S. consumer credit market and susceptibility to market fluctuations and legislative and regulatory developments; our ability to successfully develop and commercialize new or enhanced products and services; our ability to realize the value of acquisitions, dispositions and strategic investments; reductions in interchange fees; fraudulent activity; failure of third-parties to provide various services that are important to our operations; international risks and compliance and regulatory risks and costs associated with international operations; alleged infringement of intellectual property rights of others and our ability to protect our intellectual property; litigation, regulatory actions and compliance issues; our ability to attract, retain and motivate key officers and employees; tax legislation initiatives or challenges to our tax positions and/or interpretations, and state sales tax rules and regulations; regulation, supervision, examination and enforcement of our business by governmental authorities, the impact of the Dodd-Frank Wall Street Reform and Consumer Protection Act (the "Dodd-Frank Act") and other legislative and regulatory developments and the impact of the CFPB's regulation of our business, including new requirements and constraints that Synchrony and the Bank are or will become subject to as a result of having $100 billion or more in total assets; impact of capital adequacy rules and liquidity requirements; restrictions that limit our ability to pay dividends and repurchase our common stock, and restrictions that limit the Bank's ability to pay dividends to us; regulations relating to privacy, information security and data protection; use of third-party vendors and ongoing third-party business relationships; and failure to comply with anti-money laundering and anti-terrorism financing laws.

For the reasons described above, we caution you against relying on any forward-looking statements, which should also be read in conjunction with the other cautionary statements that are included elsewhere in this report and in our public filings, including under the heading *"Risk Factors Relating to Our Business"* and *"Risk Factors Relating to Regulation"* in our 2024 Form 10-K. You should not consider any list of such factors to be an exhaustive statement of all of the risks, uncertainties, or potentially inaccurate assumptions that could cause our current expectations or beliefs to change. Further, any forward-looking statement, including under the heading *"Business Trends and Conditions"* below, speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as otherwise may be required by law.

------

**PART I. FINANCIAL INFORMATION**

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes included elsewhere in this quarterly report and in our 2024 Form 10-K. The discussion below contains forward-looking statements that are based upon current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from these expectations. See "*Cautionary Note Regarding Forward-Looking Statements*."

**Introduction and Business Overview ____________________________________________________________________________________________**

We are a premier consumer financial services company delivering one of the industry's most complete digitally-enabled product suites. Our experience, expertise and scale encompass a broad spectrum of industries including digital, health and wellness, retail, telecommunications, home, auto, outdoor, pet and more. We have an established and diverse group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations and healthcare service providers, which we refer to as our "partners." For the three and six months ended June 30, 2025, we financed $46.1 billion and $86.8 billion of purchase volume, respectively and had 68.1 million and 68.8 million average active accounts, respectively and at June 30, 2025, we had $99.8 billion of loan receivables.

We offer our credit products primarily through our wholly-owned subsidiary, the Bank. In addition, through the Bank, we offer, directly to retail, affinity relationships and commercial customers, a range of deposit products insured by the Federal Deposit Insurance Corporation ("FDIC"), including certificates of deposit, individual retirement accounts ("IRAs"), money market accounts, savings accounts and sweep and affinity deposits. We also take deposits at the Bank through third-party firms that offer our FDIC-insured deposit products to their customers. Our deposit base has continued to serve as a source of stable and diversified low-cost funding for our credit activities. At June 30, 2025, we had $82.3 billion in deposits, which represented 84% of our total funding sources.

**Our Sales Platforms**

**____________________________________________________________________________________________**

We conduct our operations through a single business segment. Profitability and expenses, including funding costs, credit losses and operating expenses, are managed for the business as a whole. Substantially all of our revenue generating activities are within the United States and are aligned through five sales platforms (Home & Auto, Digital, Diversified & Value, Health & Wellness and Lifestyle). Those platforms are organized by the types of partners we work with, and are measured on interest and fees on loans, loan receivables, active accounts and other sales metrics.

![Platformpies.jpg](syf-20250630_g2.jpg)

------

**Home & Auto** 

Our Home & Auto sales platform provides comprehensive payments and financing solutions with integrated in-store and digital experiences through a broad network of partners and merchants providing home and automotive merchandise and services, as well as our Synchrony Car Care network and Synchrony HOME credit card offering. In March 2024, we completed our acquisition of Ally Financial Inc.'s point-of-sale financing business ("Ally Lending"), which deepened our presence in the home improvement sector, including specialty areas such as roofing, HVAC and windows. Our Home & Auto sales platform partners include a wide range of key retailers in the home improvement, furniture, bedding, flooring, appliance and electronics industry, such as Ashley HomeStores, Inc., Floor & Decor, Lowe's, and Mattress Firm, as well as automotive merchandise and services, such as Chevron and Discount Tire. In addition, we also have program agreements with manufacturers, buying groups and industry associations, such as Generac, Nationwide Marketing Group and the Home Furnishings Association.

**Digital** 

Our Digital sales platform provides comprehensive payments and financing solutions with integrated digital experiences through partners and merchants who primarily engage with their consumers through digital channels. Our Digital sales platform includes key partners delivering digital payment solutions, such as PayPal, including our Venmo program, online marketplaces, such as Amazon and eBay, and digital-first brands and merchants, such as the Qurate brands, Verizon, and Virgin Red.

**Diversified & Value** 

Our Diversified & Value sales platform provides comprehensive payments and financing solutions with integrated in-store and digital experiences through large retail partners who deliver everyday value to consumers shopping for daily needs or important life moments. Our Diversified & Value sales platform is comprised of five large retail partners: Belk, Fleet Farm, JCPenney, Sam's Club and TJX Companies, Inc.

**Health & Wellness**

Our Health & Wellness sales platform provides comprehensive healthcare payments and financing solutions, through a network of providers and retail locations, for those seeking health and wellness care for themselves, their families and their pets, and includes our CareCredit brand, as well as partners such as Walgreens.

**Lifestyle**

Lifestyle provides comprehensive payments and financing solutions with integrated in-store and digital experiences through partners and merchants who offer merchandise in power sports, outdoor power equipment, and other industries such as sporting goods, apparel, jewelry and music. Our Lifestyle sales platform partners include a wide range of key retailers in the apparel, specialty retail, outdoor, music and luxury industry, such as American Eagle, Dick's Sporting Goods, Guitar Center, Kawasaki, Pandora, Polaris, Suzuki and Sweetwater.

**Corp, Other**

Corp, Other includes activity and balances related to certain program agreements with retail partners and merchants that will not be renewed beyond their current expiration date and certain programs that were previously terminated, which are not managed within the five sales platforms discussed above. Corp, Other also includes amounts related to changes in the fair value of equity investments and realized gains or losses associated with the sale of businesses and investments.

------

**Our Credit Products**

**____________________________________________________________________________________________**

Through our sales platforms, we offer three principal types of credit products: credit cards, commercial credit products and consumer installment loans. We also offer our Payment Security program, which is a debt cancellation product.

The following table sets forth each credit product by type and indicates the percentage of our total loan receivables that are under standard terms only or pursuant to a promotional financing offer at June 30, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Promotional Offer** | **Promotional Offer** | |
| **Credit Product** |<br>**Standard Terms Only** | **Deferred Interest** | **Other Promotional** |<br>**Total** |
| Credit cards | 61.4% | 18.0% | 12.8% | 92.2% |
| Commercial credit products | 2.0 |  |  | 2.0 |
| Consumer installment loans |  | 0.2 | 5.5 | 5.7 |
| Other | 0.1 |  |  | 0.1 |
| **Total** | 63.5% | 18.2% | 18.3% | 100.0% |

---

**Credit Cards**

We offer the following principal types of credit cards:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Private Label Credit Cards.*** Private label credit cards are partner-branded credit cards (e.g., Lowe's or Amazon) or program-branded credit cards (e.g., Synchrony Car Care or CareCredit) that are used primarily for the purchase of goods and services from the partner or within the program network. In addition, in some cases, cardholders may be permitted to access their credit card accounts for cash advances. Credit under our private label credit cards typically is extended either on standard terms only or pursuant to a promotional financing offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Dual Cards and General Purpose Co-Branded Cards.*** Our patented Dual Cards are credit cards that function as private label credit cards when used to purchase goods and services from our partners, and as general purpose credit cards when used to make purchases from other retailers wherever cards from those card networks are accepted or for cash advance transactions. We also offer general purpose co-branded credit cards that do not function as private label credit cards, as well as a Synchrony-branded general purpose credit card. Dual Cards and general purpose co-branded credit cards are offered across all of our sales platforms and credit is typically extended on standard terms only. We offer either Dual Cards or general purpose co-branded credit cards through over 15 of our large partners, of which the majority are Dual Cards, as well as our CareCredit Dual Card. Consumer Dual Cards and co-branded cards totaled 28% of our total loan receivables portfolio at June 30, 2025.

**Commercial Credit Products**

We offer private label cards and Dual Cards for commercial customers that are similar to our consumer offerings. We also offer a commercial pay-in-full accounts receivable product to a wide range of business customers.

**Installment Loans**

We originate secured installment loans to consumers (and a limited number of commercial customers) in the United States, primarily for power products in our Outdoor market (motorcycles, ATVs and lawn and garden). We also offer unsecured installment loans primarily in our Home & Auto and Health & Wellness sales platforms and through our various other installment products, such as our Synchrony Pay Later solutions, including pay monthly and Pay in 4 products, for short-term loans. Installment loans are closed-end credit accounts where the customer pays down the outstanding balance in installments. Installment loans are generally assessed periodic finance charges using fixed interest rates.

------

**Business Trends and Conditions**

**____________________________________________________________________________________________**

We believe our business and results of operations will be impacted in the future by various trends and conditions. For a discussion of certain trends and conditions, see "*Management's Discussion and Analysis of Financial Condition and Results of Operations—Business Trends and Conditions*" in our 2024 Form 10-K and see below for recent developments. For a discussion of how certain trends and conditions impacted the three and six months ended June 30, 2025, see "—*Results of Operations.*"

***CFPB final rule on credit card late fees.***

On March 5, 2024, the CFPB released a final rule amending its regulations that implement the Truth in Lending Act to lower the safe harbor dollar amount for credit card late fees from the prior $30 (adjusted to $41 for each subsequent late payment within the next six billing cycles) to $8 and to eliminate the automatic annual inflation adjustment to such safe harbor dollar amount. The final rule had an original effective date of May 14, 2024. Industry organizations challenged the final rule in court, and on May 10, 2024, the United States District Court for the Northern District of Texas granted an injunction and stay of the final rule.

On April 14, 2025, in the litigation challenging the final late fee rule, the CFPB and the plaintiff industry organizations filed a joint motion asking the court to vacate the final rule and dismiss the case. On April 15, 2025, the court granted this motion. As such, the final rule has been vacated.

In anticipation that the final rule would become effective, we implemented a number of product, pricing and policy changes in the prior year. In light of the final rule being vacated, we have incorporated the review of these product, pricing and policy changes with our partners into our usual business practice of monitoring overall program performance, including assessing whether any adjustments to these changes are warranted. As a result of these reviews, we expect to make minor modifications to these changes in 2025.

***Extended duration of our credit card program agreements.***

In July 2025, we extended our program agreement with Amazon, one of our five largest programs based upon interest and fees on loans for the year ended December 31, 2024. Following the renewal of this program, the current expiration dates for program agreements with our five largest partners range from 2030 through 2035. In addition, during the six months ended June 30, 2025, we have added or renewed over 25 partners, including our program agreement with Amazon. As a result, a total of 22 of our 25 largest program agreements now have an expiration date in 2027 or beyond. These 22 program agreements represented, in the aggregate as a percentage of the total attributable to our 25 largest programs, 98% of our interest and fees on loans for the year ended December 31, 2024 and 97% of our loan receivables at December 31, 2024.

------

**Seasonality**

**____________________________________________________________________________________________**

We experience fluctuations in purchase volume and the level of loan receivables as a result of higher seasonal consumer spending and payment patterns that typically result in an increase of loan receivables from August through a peak in late December, with reductions in loan receivables typically occurring over the first and second quarters of the following year as customers pay their balances down.

The seasonal impact to purchase volume and the loan receivables balance typically results in fluctuations in our results of operations, delinquency metrics and the allowance for credit losses as a percentage of total loan receivables between quarterly periods. These fluctuations are generally most evident between the fourth quarter and the first quarter of the following year.

In addition to the seasonal variance in loan receivables discussed above, we also typically experience a seasonal increase in delinquency rates and delinquent loan receivables balances during the third and fourth quarters of each year due to lower customer payment rates, resulting in higher net charge-off rates in the first half of the calendar year. Our delinquency rates and delinquent loan receivables balances typically decrease during the subsequent first and second quarters as customers begin to pay down their loan balances and return to current status, resulting in lower net charge-off rates in the second half of the calendar year. Because customers who were delinquent during the fourth quarter of a calendar year have a higher probability of returning to current status when compared to customers who are delinquent at the end of each of our interim reporting periods, we expect that a higher proportion of delinquent accounts outstanding at an interim period end will result in charge-offs, as compared to delinquent accounts outstanding at a year end. Consistent with this historical experience, we generally experience a higher allowance for credit losses as a percentage of total loan receivables at the end of an interim period, as compared to the end of a calendar year. In addition, even in instances of improving credit metrics such as declining past due amounts, we may experience an increase in our allowance for credit losses at an interim period end compared to the prior year end, reflecting these same seasonal trends.

------

**Results of Operations** 

**____________________________________________________________________________________________**

**Highlights for the Three and Six Months Ended June 30, 2025** 

Below are highlights of our performance for the three and six months ended June 30, 2025 compared to the three and six months ended June 30, 2024, as applicable, except as otherwise noted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net earnings increased to $967 million from $643 million and decreased to $1.7 billion from $1.9 billion for the three and six months ended June 30, 2025, respectively. The increase in the three months ended June 30, 2025 was primarily driven by a decrease in provision for credit losses, partially offset by higher retailer share arrangements. The decrease in the six months ended June 30, 2025 was primarily driven by the after-tax gain on sale related to Pets Best of $802 million in the prior year, and higher retailer share arrangements, partially offset by a decrease in provision for credit losses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Loan receivables decreased 2.5% to $99.8 billion at June 30, 2025 compared to $102.3 billion at June 30, 2024, primarily reflecting the impact of lower purchase volume and higher payment rates, as well as the reclassification of $0.2 billion of loan receivables to loan receivables held for sale.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net interest income increased 2.6% to $4.5 billion and 2.0% to $9.0 billion for the three and six months ended June 30, 2025, respectively, primarily driven by higher loan receivables yield and a reduction in interest expense. For the three and six months ended June 30, 2025, interest expense decreased 9.5% and 8.1%, respectively, primarily due to lower interest-bearing liabilities cost associated with lower benchmark rates. Interest and fees on loans increased 0.5% and 0.4% for the three and six months ended June 30, 2025, respectively, primarily reflecting the impact of our product, pricing and policy changes, partially offset by a combination of lower benchmark rates and lower late fee incidence.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Retailer share arrangements increased 22.5% to $992 million and 19.9% to $1.9 billion for the three and six months ended June 30, 2025, respectively, primarily reflecting lower net charge-offs and the impact of our product, pricing and policy changes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** Over-30 day loan delinquencies as a percentage of period-end loan receivables decreased 29 basis points to 4.18% at June 30, 2025 compared to June 30, 2024. The net charge-off rate decreased 72 basis points to 5.70% for the three and six months ended June 30, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Provision for credit losses decreased by $545 million, or 32.2%, and $938 million, or 26.2%, for the three and six months ended June 30, 2025, respectively, primarily driven by reserve releases in the current year as compared to builds in the prior year, as well as lower net charge-offs. Our allowance coverage ratio (allowance for credit losses as a percentage of period-end loan receivables) decreased to 10.59% at June 30, 2025, as compared to 10.74% at June 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Other income increased by $1 million to $118 million, and decreased by $1.0 billion to $267 million for the three and six months ended June 30, 2025, respectively. The increase in the three months ended June 30, 2025 was primarily driven by the impact of our product, pricing and policy change related fees in the current year period, partially offset by a gain of $51 million related to an exchange of Visa Class B-1 common stock in the prior year period. The decrease in the six months ended June 30, 2025 was primarily driven by the $1.1 billion gain on sale related to Pets Best in the prior year, partially offset by the impact of our product, pricing and policy change related fees in the current year period.&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** Other expense increased by $68 million, or 5.8%, and $105 million, or 4.4%, for the three and six months ended June 30, 2025, respectively. The increases in the three and six months ended June 30, 2025 were primarily driven by higher employee costs, partially offset by lower operational losses and late fee rule preparatory expenses in the prior year. The increase in the six months ended June 30, 2025 was also driven by costs related to technology investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• At June 30, 2025, deposits represented 84% of our total funding sources. Total deposits increased by 0.2% to $82.3 billion at June 30, 2025, compared to December 31, 2024.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** During the six months ended June 30, 2025, we declared and paid cash dividends totaling $42 million on our Series A 5.625% fixed rate non-cumulative perpetual preferred stock and our Series B 8.250% fixed rate reset non-cumulative perpetual preferred stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** During the six months ended June 30, 2025, we repurchased $1.1 billion of our outstanding common stock, and declared and paid cash dividends of $0.55 per share, or $211 million in the aggregate. In April 2025 we announced that the Board of Directors approved a new share repurchase program of up to $2.5 billion, through June 30, 2026, and increased our quarterly dividend to $0.30 per common share commencing in the second quarter of 2025. At June 30, 2025 we had a total share repurchase authorization of $2.0 billion remaining. For more information, see "Capital—Dividend and Share Repurchases."

***2025 Partner Agreements***

During the six months ended June 30, 2025, and to date, we continued to expand and diversify our portfolio with the addition or renewal of more than 25 partners, which included the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In our Home & Auto sales platform, we extended our program agreements with Ashley HomeStores, Inc., Discount Tire, Gardner White and Home Furnishings Association.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In our Digital sales platform, we announced our new partnership with Sun Country Airlines and extended our program agreement with Amazon.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In our Diversified & Value sales platform, we announced our new partnership with OnePay to become the exclusive issuer of a general purpose and private label credit card program at Walmart

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In our Health & Wellness sales platform, we expanded our network through our new partnership with Texas A&M University Veterinary Medical Teaching Hospital.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In our Lifestyle sales platform, we extended our program agreement with American Eagle.

During the second quarter of 2025, we also entered into an agreement to sell loan receivables associated with a Home & Auto partner program agreement. The sale of the portfolio, which is subject to customary closing conditions, is expected to be completed in the fourth quarter of 2025.

**Summary Earnings**

The following table sets forth our results of operations for the periods indicated.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Interest income | $5586 | $5582 | $11136 | $11150 |
| Interest expense | 1065 | 1177 | 2151 | 2340 |
| **Net interest income** | 4521 | 4405 | 8985 | 8810 |
| Retailer share arrangements | (992) | (810) | (1887) | (1574) |
| Provision for credit losses | 1146 | 1691 | 2637 | 3575 |
| **Net interest income, after retailer share arrangements and provision for credit losses** | 2383 | 1904 | 4461 | 3661 |
| Other income | 118 | 117 | 267 | 1274 |
| Other expense | 1245 | 1177 | 2488 | 2383 |
| **Earnings before provision for income taxes** | 1256 | 844 | 2240 | 2552 |
| Provision for income taxes | 289 | 201 | 516 | 616 |
| **Net earnings** | $967 | $643 | $1724 | $1936 |
| **Net earnings available to common stockholders** | $946 | $624 | $1682 | $1906 |

---

------

**Other Financial and Statistical Data**

The following table sets forth certain other financial and statistical data for the periods indicated.&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **At and for the** | **At and for the** | **At and for the** | **At and for the** |
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| **Financial Position Data (Average):** |  |  |  |  |
| Loan receivables, including held for sale | $99236 | $101478 | $100123 | $101218 |
| Total assets | $120441 | $119864 | $120467 | $119450 |
| Deposits | $82426 | $83145 | $82606 | $83067 |
| Borrowings | $16195 | $15976 | $16119 | $15994 |
| Total equity | $16755 | $15522 | $16726 | $15067 |
| **Selected Performance Metrics:** |  |  |  |  |
| Purchase volume<sup>(1)(2)</sup> | $46084 | $46846 | $86804 | $89233 |
| &nbsp;&nbsp;&nbsp;&nbsp;Home & Auto | $11459 | $12350 | $20905 | $22741 |
| &nbsp;&nbsp;&nbsp;&nbsp;Digital | $13647 | $13403 | $26126 | $26031 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diversified & Value | $15393 | $15333 | $29125 | $29356 |
| &nbsp;&nbsp;&nbsp;&nbsp;Health & Wellness | $4007 | $4089 | $7781 | $8069 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lifestyle | $1432 | $1525 | $2600 | $2769 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corp, Other | $146 | $146 | $267 | $267 |
| Average active accounts (in thousands)<sup>(2)(3)</sup> | 68050 | 70974 | 68810 | 71402 |
| Net interest margin<sup>(4)</sup> | 14.78% | 14.46% | 14.76% | 14.50% |
| Net charge-offs | $1411 | $1621 | $2999 | $3206 |
| Net charge-offs (annualized) as a % of average loan receivables, including held for sale | 5.70% | 6.42% | 6.04% | 6.37% |
| Allowance coverage ratio<sup>(5)</sup> | 10.59% | 10.74% | 10.59% | 10.74% |
| Return on assets<sup>(6)</sup> | 3.2% | 2.2% | 2.9% | 3.3% |
| Return on equity<sup>(7)</sup> | 23.1% | 16.7% | 20.8% | 25.8% |
| Equity to assets<sup>(8)</sup> | 13.91% | 12.95% | 13.88% | 12.61% |
| Other expense (annualized) as a % of average loan receivables, including held for sale | 5.03% | 4.66% | 5.01% | 4.73% |
| Efficiency ratio<sup>(9)</sup> | 34.1% | 31.7% | 33.8% | 28.0% |
| Effective income tax rate | 23.0% | 23.8% | 23.0% | 24.1% |
| **Selected Period-End Data:** |  |  |  |  |
| Loan receivables | $99776 | $102284 | $99776 | $102284 |
| Allowance for credit losses | $10564 | $10982 | $10564 | $10982 |
| 30+ days past due as a % of period-end loan receivables<sup>(10)</sup> | 4.18% | 4.47% | 4.18% | 4.47% |
| 90+ days past due as a % of period-end loan receivables<sup>(10)</sup> | 2.06% | 2.19% | 2.06% | 2.19% |
| Total active accounts (in thousands)<sup>(2)(3)</sup> | 68186 | 70991 | 68186 | 70991 |

---

______________________

(1)Purchase volume, or net credit sales, represents the aggregate amount of charges incurred on credit cards or other credit product accounts less returns during the period.

(2)Includes activity and accounts associated with loan receivables held for sale.

(3)Active accounts represent credit card or installment loan accounts on which there has been a purchase, payment or outstanding balance in the current month.&nbsp;&nbsp;&nbsp;&nbsp;

(4)Net interest margin represents annualized net interest income divided by average total interest-earning assets.

(5)Allowance coverage ratio represents allowance for credit losses divided by total period-end loan receivables.

(6)Return on assets represents annualized net earnings as a percentage of average total assets.

(7)Return on equity represents annualized net earnings as a percentage of average total equity.

(8)Equity to assets represents average total equity as a percentage of average total assets.

(9)Efficiency ratio represents (i) other expense, divided by (ii) sum of net interest income, plus other income, less retailer share arrangements.

(10)Based on customer statement-end balances extrapolated to the respective period-end date.

------

**Average Balance Sheet**

The following tables set forth information for the periods indicated regarding average balance sheet data, which are used in the discussion of interest income, interest expense and net interest income that follows.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| *Three months ended June 30 ($ in millions)* | **Average<br>Balance** | **Interest<br>Income /<br>Expense** | **Average**<br>**Yield /**<br>**Rate**<sup>(1)</sup> | **Average<br>Balance** | **Interest<br>Income/<br>Expense** | **Average**<br>**Yield /**<br>**Rate**<sup>(1)</sup> |
| **Assets** |  |  |  |  |  |  |
| **Interest-earning assets:** |  |  |  |  |  |  |
| Interest-earning cash and equivalents<sup>(2)</sup> | $20699 | $228 | 4.42% | $18337 | $249 | 5.46% |
| Securities available for sale | 2774 | 30 | 4.34% | 2731 | 32 | 4.71% |
| **Loan receivables, including held for sale**<sup>(3)</sup>**:** |  |  |  |  |  |  |
| Credit cards | 91460 | 5076 | 22.26% | 93267 | 5013 | 21.62% |
| Consumer installment loans | 5692 | 207 | 14.59% | 6085 | 243 | 16.06% |
| Commercial credit products | 1981 | 43 | 8.71% | 2001 | 43 | 8.64% |
| Other | 103 | 2 | 7.79% | 125 | 2 | 6.44% |
| **Total loan receivables, including held for sale** | 99236 | 5328 | 21.54% | 101478 | 5301 | 21.01% |
| **Total interest-earning assets** | 122709 | 5586 | 18.26% | 122546 | 5582 | 18.32% |
| **Non-interest-earning assets:** |  |  |  |  |  |  |
| Cash and due from banks | 868 |  |  | 887 |  |  |
| Allowance for credit losses | (10797) |  |  | (10878) |  |  |
| Other assets | 7661 |  |  | 7309 |  |  |
| **Total non-interest-earning assets** | (2268) |  |  | (2682) |  |  |
| **Total assets** | $120441 |  |  | $119864 |  |  |
| **Liabilities** |  |  |  |  |  |  |
| **Interest-bearing liabilities:** |  |  |  |  |  |  |
| Interest-bearing deposit accounts | $82014 | $855 | 4.18% | $82749 | $967 | 4.70% |
| Borrowings of consolidated securitization entities | 7926 | 104 | 5.26% | 7858 | 110 | 5.63% |
| Senior and subordinated unsecured notes | 8269 | 106 | 5.14% | 8118 | 100 | 4.95% |
| **Total interest-bearing liabilities** | 98209 | 1065 | 4.35% | 98725 | 1177 | 4.80% |
| **Non-interest-bearing liabilities:** |  |  |  |  |  |  |
| Non-interest-bearing deposit accounts | 412 |  |  | 396 |  |  |
| Other liabilities | 5065 |  |  | 5221 |  |  |
| **Total non-interest-bearing liabilities** | 5477 |  |  | 5617 |  |  |
| **Total liabilities** | 103686 |  |  | 104342 |  |  |
| **Equity** |  |  |  |  |  |  |
| **Total equity** | 16755 |  |  | 15522 |  |  |
| **Total liabilities and equity** | $120441 |  |  | $119864 |  |  |
| **Interest rate spread**<sup>(4)</sup> |  |  | 13.91% |  |  | 13.53% |
| **Net interest income** |  | $4521 |  |  | $4405 |  |
| **Net interest margin**<sup>(5)</sup> |  |  | 14.78% |  |  | 14.46% |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| *Six months ended June 30 ($ in millions)* | **Average<br>Balance** | **Interest<br>Income /<br>Expense** | **Average**<br>**Yield /**<br>**Rate**<sup>(1)</sup> | **Average<br>Balance** | **Interest<br>Income/<br>Expense** | **Average**<br>**Yield /**<br>**Rate**<sup>(1)</sup> |
| **Assets** |  |  |  |  |  |  |
| **Interest-earning assets:** |  |  |  |  |  |  |
| Interest-earning cash and equivalents<sup>(2)</sup> | $19625 | $431 | 4.43% | $17871 | $485 | 5.46% |
| Securities available for sale | 3001 | 65 | 4.37% | 3082 | 71 | 4.63% |
| **Loan receivables, including held for sale**<sup>(3)</sup>**:** |  |  |  |  |  |  |
| Credit cards | 92345 | 10131 | 22.12% | 93743 | 10109 | 21.69% |
| Consumer installment loans | 5762 | 418 | 14.63% | 5409 | 392 | 14.57% |
| Commercial credit products | 1912 | 88 | 9.28% | 1939 | 88 | 9.13% |
| Other | 104 | 3 | 5.82% | 127 | 5 | 7.92% |
| **Total loan receivables, including held for sale** | 100123 | 10640 | 21.43% | 101218 | 10594 | 21.05% |
| **Total interest-earning assets** | 122749 | 11136 | 18.29% | 122171 | 11150 | 18.35% |
| **Non-interest-earning assets:** |  |  |  |  |  |  |
| Cash and due from banks | 868 |  |  | 915 |  |  |
| Allowance for credit losses | (10866) |  |  | (10777) |  |  |
| Other assets | 7716 |  |  | 7141 |  |  |
| **Total non-interest-earning assets** | (2282) |  |  | (2721) |  |  |
| **Total assets** | $120467 |  |  | $119450 |  |  |
| **Liabilities** |  |  |  |  |  |  |
| **Interest-bearing liabilities:** |  |  |  |  |  |  |
| Interest-bearing deposit accounts | $82191 | $1737 | 4.26% | $82674 | $1921 | 4.67% |
| Borrowings of consolidated securitization entities | 8058 | 208 | 5.21% | 7620 | 215 | 5.67% |
| Senior and subordinated unsecured notes | 8061 | 206 | 5.15% | 8374 | 204 | 4.90% |
| **Total interest-bearing liabilities** | 98310 | 2151 | 4.41% | 98668 | 2340 | 4.77% |
| **Non-interest-bearing liabilities:** |  |  |  |  |  |  |
| Non-interest-bearing deposit accounts | 415 |  |  | 393 |  |  |
| Other liabilities | 5016 |  |  | 5322 |  |  |
| **Total non-interest-bearing liabilities** | 5431 |  |  | 5715 |  |  |
| **Total liabilities** | 103741 |  |  | 104383 |  |  |
| **Equity** |  |  |  |  |  |  |
| **Total equity** | 16726 |  |  | 15067 |  |  |
| **Total liabilities and equity** | $120467 |  |  | $119450 |  |  |
| **Interest rate spread**<sup>(4)</sup> |  |  | 13.88% |  |  | 13.58% |
| **Net interest income** |  | $8985 |  |  | $8810 |  |
| **Net interest margin**<sup>(5)</sup> |  |  | 14.76% |  |  | 14.50% |

---

________________________________________

(1)Average yields/rates are based on annualized total interest income/expense divided by average balances.

(2)Includes average restricted cash balances of $642 million and $61 million for the three months ended June 30, 2025 and 2024, respectively, and $666 million and $85 million for the six months ended June 30, 2025 and 2024, respectively.

(3)Interest income on loan receivables includes fees on loans, which primarily consist of late fees on our credit products, of $560 million and $609 million for the three months ended June 30, 2025 and 2024, respectively, and $1.1 billion and $1.3 billion for the six months ended June 30, 2025 and 2024, respectively.

(4)Interest rate spread represents the difference between the yield on total interest-earning assets and the rate on total interest-bearing liabilities.

(5)Net interest margin represents annualized net interest income divided by average total interest-earning assets.

------

For a summary description of the composition of our key line items included in our Statements of Earnings, see *Management's Discussion and Analysis of Financial Condition and Results of Operations* in our 2024 Form 10-K.

**Interest Income**

Interest income was flat for the three and six months ended June 30, 2025, reflecting higher interest and fees on loans, offset by lower interest income from our liquidity portfolio. The trend in interest and fees on loans reflects the impacts of our product, pricing and policy changes, offset by a combination of lower benchmark rates and lower late fee incidence, as well as a decrease in average loan receivables.

***Average interest-earning assets*** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| *Three months ended June 30 ($ in millions)* | **2025** | **%** | **2024** | **%** |
| Loan receivables, including held for sale | $99236 | 80.9% | $101478 | 82.8% |
| Liquidity portfolio and other | 23473 | 19.1% | 21068 | 17.2% |
| **Total average interest-earning assets** | $122709 | 100.0% | $122546 | 100.0% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| *Six months ended June 30 ($ in millions)* | **2025** | **%** | **2024** | **%** |
| Loan receivables, including held for sale | $100123 | 81.6% | $101218 | 82.8% |
| Liquidity portfolio and other | 22626 | 18.4% | 20953 | 17.2% |
| **Total average interest-earning assets** | $122749 | 100.0% | $122171 | 100.0% |

---

Average loan receivables, including held for sale, decreased 2.2% and 1.1% for the three and six months ended June 30, 2025, respectively, primarily driven by lower purchase volume and higher payment rates. Purchase volume decreased by 1.6% and 2.7% for the three and six months ended June 30, 2025, respectively, reflecting selective consumer spending as well as the impact of previous credit actions.

***Yield on average interest-earning assets***

The yield on average interest-earning assets decreased for the three and six months ended June 30, 2025 primarily due to a decrease in the percentage of interest-earning assets attributable to loan receivables and a lower yield on our liquidity portfolio, partially offset by an increase in the yield on average loan receivables. The loan receivable yield increased 53 basis points to 21.54% and 38 basis points to 21.43% for the three and six months ended June 30, 2025, driven by the impacts of our product, pricing and policy changes, partially offset by a combination of lower benchmark rates and lower late fee incidence.

**Interest Expense** 

Interest expense decreased by $112 million to $1.1 billion and $189 million to $2.2 billion, for the three and six months ended June 30, 2025, respectively, primarily due to lower interest-bearing liabilities cost associated with lower benchmark rates. Our cost of funds decreased to 4.35% and 4.41% for the three and six months ended June 30, 2025, respectively, compared to 4.80% and 4.77% for the three and six months ended June 30, 2024, respectively.

***Average interest-bearing liabilities***

---

| | | | | |
|:---|:---|:---|:---|:---|
| *Three months ended June 30 ($ in millions)* | **2025** | **%** | **2024** | **%** |
| Interest-bearing deposit accounts | $82014 | 83.5% | $82749 | 83.8% |
| Borrowings of consolidated securitization entities | 7926 | 8.1% | 7858 | 8.0% |
| Senior and subordinated unsecured notes | 8269 | 8.4% | 8118 | 8.2% |
| **Total average interest-bearing liabilities** | $98209 | 100.0% | $98725 | 100.0% |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| *Six months ended June 30 ($ in millions)* | **2025** | **%** | **2024** | **%** |
| Interest-bearing deposit accounts | $82191 | 83.6% | $82674 | 83.8% |
| Borrowings of consolidated securitization entities | 8058 | 8.2% | 7620 | 7.7% |
| Senior and subordinated unsecured notes | 8061 | 8.2% | 8374 | 8.5% |
| **Total average interest-bearing liabilities** | $98310 | 100.0% | $98668 | 100.0% |

---

**Net Interest Income**

Net interest income increased by $116 million, or 2.6%, and $175 million, or 2.0%, for the three and six months ended June 30, 2025, respectively, resulting from the changes in interest income and interest expense discussed above.

**Retailer Share Arrangements**

Retailer share arrangements increased by $182 million, or 22.5% and $313 million to 19.9%, for the three and six months ended June 30, 2025, respectively, reflecting lower net charge-offs and the impact of our product, pricing and policy changes.

**Provision for Credit Losses**

Provision for credit losses decreased by $545 million, or 32.2%, and $938 million, or 26.2%, for the three and six months ended June 30, 2025, respectively, primarily driven by reserve releases in the current year as compared to reserve builds in the prior year, as well as lower net charge-offs. The reserve releases for the three and six months ended June 30, 2025 were $265 million and $362 million, respectively, as compared to reserve builds of $70 million and $369 million, respectively, in the prior year periods. The reserve build in the six months ended June 30, 2024 included $180 million related to the Ally Lending acquisition.

Net charge-offs for the three and six months ended June 30, 2025 decreased by $210 million and $207 million, respectively. The net charge-off rate for the three and six months ended June 30, 2025 decreased by 72 basis points to 5.70%, and 33 basis points to 6.04%, respectively, as compared to the prior year periods.

**Other Income**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Interchange revenue | $268 | $263 | $506 | $504 |
| Protection product revenue | 144 | 125 | 291 | 266 |
| Loyalty programs | (360) | (346) | (671) | (665) |
| Other | 66 | 75 | 141 | 1169 |
| **Total other income** | $118 | $117 | $267 | $1274 |

---

Other income increased by $1 million to $118 million, and decreased by $1.0 billion, to $267 million, for the three and six months ended June 30, 2025, respectively.

The increase in the three months ended June 30, 2025 was primarily driven by the impact of our product, pricing and policy change related fees in the current year period, partially offset by a gain of $51 million related to an exchange of Visa Class B-1 common stock in the prior year period.

The decrease in the six months ended June 30, 2025 was primarily driven by the $1.1 billion gain on sale related to Pets Best in the prior year, partially offset by the impact of our product, pricing and policy change related fees in the current year period.

------

**Other Expense**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Employee costs | $509 | $434 | $1015 | $930 |
| Professional fees | 236 | 236 | 453 | 456 |
| Marketing and business development | 127 | 129 | 243 | 254 |
| Information processing | 215 | 207 | 434 | 393 |
| Other | 158 | 171 | 343 | 350 |
| **Total other expense** | $1245 | $1177 | $2488 | $2383 |

---

Other expense increased by $68 million, or 5.8%, and $105 million, or 4.4% for the three and six months ended June 30, 2025, respectively.

The increase in the three months ended June 30, 2025 was primarily driven by an increase in employee costs, partially offset by lower operational losses and late fee rule preparatory expenses in the prior year. The increase in employee costs was primarily driven by higher variable compensation, as well as additional headcount to support technology investments and higher medical benefit costs. The increase in variable compensation included mark-to-market adjustments for deferred compensation plans, higher stock-based compensation expense and higher incentive compensation, including an inflation bonus for our non-exempt employees.

The increase in the six months ended June 30, 2025 was also driven by higher information processing costs related to technology investments, in addition to the factors discussed above for the three months ended June 30, 2025.

**Provision for Income Taxes**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Effective tax rate | 23.0% | 23.8% | 23.0% | 24.1% |
| Provision for income taxes | $289 | $201 | $516 | $616 |

---

The effective tax rate for the three and six months ended June 30, 2025 decreased compared to the same period in the prior year primarily due to an increase in tax benefits from stock-based compensation combined with a tax benefit from remeasuring the deferred tax asset for increases in state tax rates in the current period. The effective tax rate differs from the applicable U.S. federal statutory tax rate primarily due to state income taxes.

On July 4, 2025, the One Big Beautiful Bill Act (the "Act") was enacted into law, which included certain modifications to U.S. tax law. The Company is currently evaluating the provisions of the Act but does not expect the Act to have a material impact on our Consolidated Financial Statements.

------

**Platform Analysis**

As discussed above under "—*Our Sales Platforms*," we offer our credit products primarily through five sales platforms (Home & Auto, Digital, Diversified & Value, Health & Wellness and Lifestyle). The following is a discussion of certain supplemental information for the three and six months ended June 30, 2025, for each of our five sales platforms and Corp, Other.

In the second quarter of 2025, we entered into an agreement to sell $0.2 billion of loan receivables associated with a Home & Auto partner program agreement. In connection with this agreement, revenue activities for the portfolio are no longer managed within our Home & Auto sales platform. All related metrics previously reported within our Home & Auto sales platform, are now reported within Corp, Other below. We have also recast all prior-period reported metrics for our Home & Auto sales platform and Corp, Other to conform to the current-period presentation.

***Home & Auto***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Purchase volume | $11459 | $12350 | $20905 | $22741 |
| Period-end loan receivables | $30374 | $32611 | $30374 | $32611 |
| Average loan receivables, including held for sale | $30137 | $32385 | $30472 | $32023 |
| Average active accounts (in thousands) | 17831 | 19205 | 17899 | 19039 |
| Interest and fees on loans | $1395 | $1409 | $2797 | $2781 |
| Other income | $52 | $37 | $108 | $69 |

---

Home & Auto interest and fees on loans decreased by $14 million, or 1.0%, and increased by $16 million, or 0.6%, for the three and six months ended June 30, 2025, respectively.

The decrease in the three months ended June 30, 2025 was primarily driven by lower average loan receivables, partially offset by higher loan receivables yield. The increase in the six months ended June 30, 2025 was primarily driven by higher loan receivables yield and the impacts of the Ally Lending acquisition in March 2024, partially offset by lower average loan receivables.

The increases in loan receivables yield reflects the impact of product, pricing and policy changes, partially offset by lower late fee incidence. The decreases in average loan receivables was primarily driven by lower purchase volume and higher payment rates. Purchase volume decreased 7.2% and 8.1% for the three and six months ended June 30, 2025, respectively, reflecting the combination of selective consumer spending amidst macroeconomic uncertainty and previous credit actions.

Other income increased by $15 million, or 40.5%, and $39 million, or 56.5%, for the three and six months ended June 30, 2025, respectively, primarily due to the impact of product, pricing and policy change related fees.

***Digital***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Purchase volume | $13647 | $13403 | $26126 | $26031 |
| Period-end loan receivables | $27786 | $27704 | $27786 | $27704 |
| Average loan receivables, including held for sale | $27571 | $27542 | $27892 | $27812 |
| Average active accounts (in thousands) | 20368 | 20920 | 20554 | 21142 |
| Interest and fees on loans | $1576 | $1544 | $3120 | $3111 |
| Other income | $— | $— | $9 | $6 |

---

------

Digital interest and fees on loans increased by $32 million, or 2.1%, and $9 million, or 0.3% for the three and six months ended June 30, 2025, respectively, primarily driven by higher loan receivable yield, which included the impacts of product, pricing and policy changes, offset by lower benchmark rates and lower late fee incidence. Purchase volume increased by 1.8% and 0.4% for the three and six months ended June 30, 2025, as growth in new accounts and consumer spend per account was partially offset by fewer active accounts, which included the impact of previous credit actions. Average active accounts decreased by 2.6% and 2.8% for the three and six months ended June 30, 2025, respectively.

***Diversified & Value***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Purchase volume | $15393 | $15333 | $29125 | $29356 |
| Period-end loan receivables | $19510 | $19516 | $19510 | $19516 |
| Average loan receivables, including held for sale | $19338 | $19360 | $19504 | $19477 |
| Average active accounts (in thousands) | 19471 | 20253 | 19858 | 20691 |
| Interest and fees on loans | $1159 | $1165 | $2337 | $2379 |
| Other income | $(3) | $(22) | $(3) | $(39) |

---

Diversified & Value interest and fees on loans decreased by $6 million, or 0.5%, and $42 million, or 1.8%, for the three and six months ended June 30, 2025, respectively, primarily driven by lower loan receivables yield, reflecting lower benchmark rates and lower late fee incidence, partially offset by the impact of product, pricing and policy changes.

Purchase volume was flat for the three and six months ended June 30, 2025, respectively, as growth in consumer spend per account was offset by fewer active accounts, which included the impact of previous credit actions. Average active accounts decreased by 3.9% and 4.0% for the three and six months ended June 30, 2025, respectively.

***Health & Wellness***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Purchase volume | $4007 | $4089 | $7781 | $8069 |
| Period-end loan receivables | $15309 | $15280 | $15309 | $15280 |
| Average loan receivables, including held for sale | $15215 | $15111 | $15247 | $14904 |
| Average active accounts (in thousands) | 7697 | 7752 | 7740 | 7670 |
| Interest and fees on loans | $923 | $911 | $1837 | $1780 |
| Other income | $66 | $48 | $141 | $114 |

---

Health & Wellness interest and fees on loans increased by $12 million, or 1.3%, and $57 million, or 3.2%, for the three and six months ended June 30, 2025, respectively. The increase in the three months ended June 30, 2025 was primarily driven by growth in average loan receivables and loan receivables yield, reflecting the impact of product, pricing and policy changes, partially offset by lower late fee incidence. The increase in the six months ended June 30, 2025 was primarily driven by growth in loan receivables yield, reflecting the impact of product, pricing and policy changes, partially offset by higher reversals.

Purchase volume decreased 2.0% and 3.6%, for the three and six months ended June 30, 2025, respectively, reflecting lower spend in industries such as Cosmetic and Dental, combined with the impact of previous credit actions, partially offset by growth in Pet and Audiology. Average active accounts decreased 0.7% and increased 0.9% for the three and six months ended June 30, 2025, respectively.

------

Other income increased by $18 million, or 37.5%, and $27 million, or 23.7%, for the three and six months ended June 30, 2025, respectively, primarily due to higher protection product revenue and the impact of product, pricing, and policy change related fees. The increase in the three months ended June 30, 2025 was partially offset by higher loyalty costs and the increase in the six months ended June 30, 2025 was partially offset by lower commission fees following the Pets Best disposition.

***Lifestyle***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Purchase volume | $1432 | $1525 | $2600 | $2769 |
| Period-end loan receivables | $6673 | $6822 | $6673 | $6822 |
| Average loan receivables, including held for sale | $6646 | $6723 | $6681 | $6677 |
| Average active accounts (in thousands) | 2531 | 2662 | 2598 | 2665 |
| Interest and fees on loans | $261 | $258 | $522 | $513 |
| Other income | $9 | $6 | $19 | $14 |

---

Lifestyle interest and fees on loans increased by $3 million, or 1.2%, and $9 million, or 1.8%, for the three and six months ended June 30, 2025, respectively. The increase for the three months ended June 30, 2025 was primarily driven by higher loan receivables yield, reflecting the impact of product, pricing and policy changes partially offset by lower benchmark rates and lower average loan receivables. The increase in the six months ended June 30, 2025 was primarily driven by higher loan receivables yield, reflecting the impact of product, pricing and policy changes partially offset by lower late fee incidence and lower benchmark rates.

Purchase volume decreased by 6.1% for both the three and six months ended June 30, 2025, respectively, primarily driven by decreases in Outdoor and Luxury, as well as in Specialty for the six months ended June 30, 2025, as consumers continued to manage discretionary spend.

***Corp, Other***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Purchase volume | $146 | $146 | $267 | $267 |
| Period-end loan receivables | $124 | $351 | $124 | $351 |
| Average loan receivables, including held for sale | $329 | $357 | $327 | $325 |
| Average active accounts (in thousands) | 152 | 182 | 161 | 195 |
| Interest and fees on loans | $14 | $14 | $27 | $30 |
| Other income | $(6) | $48 | $(7) | $1110 |

---

Other income for the six months ended June 30, 2024 in Corp, Other primarily included the gain on sale related to the Pets Best disposition of $1.1 billion.

------

**Loan Receivables**

**____________________________________________________________________________________________**

Loan receivables are our largest category of assets and represent our primary source of revenue. The following discussion provides supplemental information regarding our loan receivables portfolio. See Note 2. *Basis of Presentation and Summary of Significant Accounting Policie*s and Note 5. *Loan Receivables and Allowance for Credit Losses* to our condensed consolidated financial statements for additional information related to our loan receivables.

The following table sets forth the composition of our loan receivables portfolio by product type at the dates indicated.

---

| | | | | |
|:---|:---|:---|:---|:---|
| *($ in millions)* | **At June 30, 2025** | **%** | **At December 31, 2024** | **%** |
| **Loan receivables** |  |  |  |  |
| Credit cards | $92036 | 92.2% | $96818 | 92.5% |
| Consumer installment loans | 5669 | 5.7 | 5971 | 5.7 |
| Commercial credit products | 1980 | 2.0 | 1826 | 1.7 |
| Other | 91 | 0.1 | 106 | 0.1 |
| **Total loan receivables** | $99776 | 100.0% | $104721 | 100.0% |

---

Loan receivables decreased 4.7% to $99.8 billion at June 30, 2025, compared to $104.7 billion at December 31, 2024, primarily driven by the seasonality of our business, lower purchase volume and higher payment rates.

Loan receivables at June 30, 2025 decreased 2.5% compared to $102.3 billion at June 30, 2024 driven by lower purchase volume and higher payment rates.

The decrease in loan receivables for both periods also included the impact of the reclassification of $0.2 billion of loan receivables to loan receivables held for sale in the second quarter of 2025.

Our loan receivables portfolio had the following geographic concentration at June 30, 2025.

---

| | | |
|:---|:---|:---|
| *($ in millions)* | **Loan Receivables<br>Outstanding** | **% of Total Loan<br>Receivables<br>Outstanding** |
| **State** | **Loan Receivables<br>Outstanding** | **% of Total Loan<br>Receivables<br>Outstanding** |
| Texas | $11002 | 11.0% |
| California | $10197 | 10.2% |
| Florida | $9343 | 9.4% |
| New York | $4725 | 4.7% |
| North Carolina | $4215 | 4.2% |

---

**Delinquencies**

Over-30 day loan delinquencies as a percentage of period-end loan receivables decreased to 4.18% at June 30, 2025 from 4.47% at June 30, 2024, and decreased from 4.70% at December 31, 2024. These decreases include the impact of the previous credit actions we have taken across our portfolio.

**Net Charge-Offs**

Net charge-offs consist of the unpaid principal balance of loans held for investment that we determine are uncollectible, net of recovered amounts. We exclude accrued and unpaid finance charges and fees and third-party fraud losses from charge-offs. Charged-off and recovered finance charges and fees are included in interest and fees on loans while third-party fraud losses are included in Other expense. Charge-offs are recorded as a reduction to the allowance for credit losses and subsequent recoveries of previously charged-off amounts are credited to the allowance for credit losses. Costs incurred to recover charged-off loans are recorded as collection expense and included in Other expense in our Condensed Consolidated Statements of Earnings.

------

The tables below sets forth the net charge-offs and ratio of annualized net charge-offs to average loan receivables, including held for sale, ("net charge-off rate") for the periods indicated.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Three months ended June 30,** | **Three months ended June 30,** |
| | **2025** | **2025** | **2024** | **2024** |
| *($ in millions)* | **Amount** | **Rate** | **Amount** | **Rate** |
| Credit cards | $1304 | 5.72% | $1493 | 6.44% |
| Consumer installment loans | 77 | 5.43% | 92 | 6.08% |
| Commercial credit products | 30 | 6.07% | 35 | 7.03% |
| Other |  | —% | 1 | 3.21% |
| Total net charge-offs | $1411 | 5.70% | $1621 | 6.42% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Six months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| | **2025** | **2025** | **2024** | **2024** |
| *($ in millions)* | **Amount** | **Rate** | **Amount** | **Rate** |
| Credit cards | $2766 | 6.04% | $2963 | 6.36% |
| Consumer installment loans | 170 | 5.95% | 174 | 6.47% |
| Commercial credit products | 63 | 6.64% | 68 | 7.05% |
| Other |  | —% | 1 | 1.58% |
| Total net charge-offs | $2999 | 6.04% | $3206 | 6.37% |

---

**Allowance for Credit Losses**

The allowance for credit losses totaled $10.6 billion at June 30, 2025, compared to $10.9 billion at December 31, 2024, respectively, and $11.0 billion at June 30, 2024, and reflects our estimate of expected credit losses for the life of the loan receivables on our Condensed Consolidated Statements of Financial Position.

The decrease in allowance for credit losses compared to December 31, 2024 and June 30, 2024 primarily reflects the decrease in both loan receivables and delinquent balances as a percentage of loan receivables, as compared to the prior year period, as well as expectations of the macroeconomic environment. Our allowance for credit losses as a percentage of total period end loan receivables increased to 10.59% at June 30, 2025, from 10.44% at December 31, 2024 and decreased from 10.74% at June 30, 2024. See Note 5. *Loan Receivables and Allowance for Credit Losses* to our condensed consolidated financial statements for additional information.

------

**Funding, Liquidity and Capital Resources**

**____________________________________________________________________________________________**

We maintain a strong focus on liquidity and capital. Our funding, liquidity and capital policies are designed to ensure that our business has the liquidity and capital resources to support our daily operations, our business growth, our credit ratings and our regulatory and policy requirements, in a cost effective and prudent manner through expected and unexpected market environments.

**Funding Sources**

Our primary funding sources include cash from operations, deposits (direct and brokered deposits), securitized financings and senior and subordinated unsecured notes.

The following tables summarize information concerning our funding sources during the periods indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| *Three months ended June 30 ($ in millions)* | **Average<br>Balance** | **%** | **Average<br>Rate** | **Average<br>Balance** | **%** | **Average<br>Rate** |
| Deposits<sup>(1)</sup> | $82014 | 83.5% | 4.2% | $82749 | 83.8% | 4.7% |
| Securitized financings | 7926 | 8.1 | 5.3% | 7858 | 8.0 | 5.6% |
| Senior and subordinated unsecured notes | 8269 | 8.4 | 5.1% | 8118 | 8.2 | 5.0% |
| **Total** | $98209 | 100.0% | 4.3% | $98725 | 100.0% | 4.8% |

---

______________________

(1)Excludes $412 million and $396 million average balance of non-interest-bearing deposits for the three months ended June 30, 2025 and 2024, respectively. Non-interest-bearing deposits comprise less than 10% of total deposits for the three months ended June 30, 2025 and 2024.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| *Six months ended June 30 ($ in millions)* | **Average<br>Balance** | **%** | **Average<br>Rate** | **Average<br>Balance** | **%** | **Average<br>Rate** |
| Deposits<sup>(1)</sup> | $82191 | 83.6% | 4.3% | $82674 | 83.8% | 4.7% |
| Securitized financings | 8058 | 8.2 | 5.2% | 7620 | 7.7 | 5.7% |
| Senior and subordinated unsecured notes | 8061 | 8.2 | 5.2% | 8374 | 8.5 | 4.9% |
| **Total** | $98310 | 100.0% | 4.4% | $98668 | 100.0% | 4.8% |

---

______________________

(1)Excludes $415 million and $393 million average balance of non-interest-bearing deposits for the six months ended June 30, 2025 and 2024, respectively. Non-interest-bearing deposits comprise less than 10% of total deposits for the six months ended June 30, 2025 and 2024.

***Deposits***

We obtain deposits directly from retail customers, affinity relationships and commercial customers ("direct deposits") and through third-party firms that offer our deposits to their customers ("brokered deposits"). At June 30, 2025, we had $73.8 billion in direct deposits and $8.5 billion in brokered deposits consisting of certificates of deposit and network deposit sweeps procured through a program arranger that channels account deposits to us. A key part of our liquidity plan and funding strategy is to continue to utilize our direct deposit base as a source of stable and diversified low-cost funding.

Our direct deposits are primarily from retail customers and include a range of FDIC-insured deposit products, including certificates of deposit, IRAs, money market accounts, savings accounts and affinity deposits.

Brokered deposits are primarily from retail customers of large brokerage firms. We have relationships with multiple brokers that offer our deposits through their networks. Our brokered deposits primarily consist of certificates of deposit that bear interest at a fixed rate. These deposits generally are not subject to early withdrawal.

------

Our ability to attract deposits is sensitive to, among other things, the interest rates we pay, and therefore, we bear funding risk if we fail to pay higher rates, or interest rate risk if we are required to pay higher rates, to retain existing deposits or attract new deposits. To mitigate these risks, our funding strategy includes a range of deposit products, and we seek to maintain access to multiple other funding sources, including securitized financings (including our undrawn committed and uncommitted capacity) and unsecured debt.

The following tables summarize certain information regarding our interest-bearing deposits by type (all of which constitute U.S. deposits) for the periods indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| *Three months ended June 30 ($ in millions)* | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| *Three months ended June 30 ($ in millions)* | **Average<br>Balance** | **%** | **Average<br>Rate** | **Average<br>Balance** | **%** | **Average<br>Rate** |
| Direct deposits: |  |  |  |  |  |  |
| &nbsp;&nbsp;Certificates of deposit <br>(including IRA certificates of deposit) | $40163 | 49.0% | 4.4% | $40698 | 49.2% | 4.8% |
| &nbsp;&nbsp;Savings, money market, and demand accounts | 33270 | 40.6 | 3.9% | 29675 | 35.9 | 4.6% |
| Brokered deposits | 8581 | 10.4 | 4.5% | 12376 | 14.9 | 4.5% |
| **Total interest-bearing deposits** | $82014 | 100.0% | 4.2% | $82749 | 100.0% | 4.7% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| *Six months ended June 30 ($ in millions)* | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| *Six months ended June 30 ($ in millions)* | **Average<br>Balance** | **%** | **Average<br>Rate** | **Average<br>Balance** | **%** | **Average<br>Rate** |
| Direct deposits: |  |  |  |  |  |  |
| &nbsp;&nbsp;Certificates of deposit <br>(including IRA certificates of deposit) | $40499 | 49.3% | 4.5% | $40694 | 49.2% | 4.8% |
| &nbsp;&nbsp;Savings, money market, and demand accounts | 32601 | 39.7 | 3.9% | 29057 | 35.2 | 4.6% |
| Brokered deposits | 9091 | 11.0 | 4.4% | 12923 | 15.6 | 4.5% |
| **Total interest-bearing deposits** | $82191 | 100.0% | 4.3% | $82674 | 100.0% | 4.7% |

---

Our deposit liabilities provide funding with maturities ranging from one day to ten years. At June 30, 2025, the weighted average maturity of our interest-bearing time deposits was approximately one year. See Note 8. *Deposits* to our condensed consolidated financial statements for more information on the maturities of our time deposits.

The standard FDIC deposit insurance amount is $250,000 per depositor, for each account ownership category. Our estimate of the uninsured portion of total deposit balances, excluding any intercompany balance, at June 30, 2025 was $6.4 billion.

The following table summarizes the portion of uninsured deposits that are certificates of deposit by contractual maturity at June 30, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| *($ in millions)* | **3 Months or<br>Less** | **Over<br>3 Months<br>but within<br>6 Months** | **Over<br>6 Months<br>but within<br>12 Months** | **Over<br>12 Months** | **Total** |
| &nbsp;&nbsp;&nbsp;Certificates of deposit (including IRA certificates of deposit) | $931 | $238 | $1488 | $1102 | $3759 |

---

***Securitized Financings***

We access the asset-backed securitization market using the Synchrony Card Issuance Trust ("SYNIT") through which we may issue asset-backed securities through both public transactions and private transactions funded by financial institutions and commercial paper conduits. In addition, we issue asset-backed securities in private transactions through the Synchrony Credit Card Master Note Trust ("SYNCT") and the Synchrony Sales Finance Master Trust ("SFT").

------

The following table summarizes expected contractual maturities of the investors' interests in securitized financings, excluding debt premiums, discounts and issuance costs at June 30, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| *($ in millions)* | **Less Than**<br>**One Year**<sup>(2)</sup> | **One Year<br>Through<br>Three<br>Years** | **Four Years<br>Through<br>Five<br>Years** | **After Five<br>Years** | **Total** |
| Scheduled maturities of borrowings—owed to securitization investors: |  |  |  |  |  |
| SYNCT | $1150 | $500 | $— | $— | $1650 |
| SFT | 400 | 875 |  |  | 1275 |
| SYNIT<sup>(1)</sup> | 675 | 4750 |  |  | 5425 |
| **Total borrowings—owed to securitization investors** | $2225 | $6125 | $— | $— | $8350 |

---

______________________

(1)Excludes any subordinated classes of SYNIT notes that we owned at June 30, 2025.

(2)Includes $675 million of fixed securitized borrowings which matured and were repaid in July 2025.

We retain exposure to the performance of trust assets through: (i) in the case of SYNCT, SFT and SYNIT, subordinated retained interests in the loan receivables transferred to the trust in excess of the principal amount of the notes for a given series that provide credit enhancement for a particular series, as well as a pari passu seller's interest in each trust and (ii) in the case of SYNIT, any subordinated classes of notes that we own.

All of our securitized financings include early repayment triggers, referred to as early amortization events, including events related to material breaches of representations, warranties or covenants, inability or failure of the Bank to transfer loan receivables to the trusts as required under the securitization documents, failure to make required payments or deposits pursuant to the securitization documents, and certain insolvency-related events with respect to the related securitization depositor, Synchrony (solely with respect to SYNCT) or the Bank. In addition, an early amortization event will occur with respect to a series if the excess spread as it relates to a particular series or for the trust, as applicable, falls below zero. Following an early amortization event, principal collections on the loan receivables in the applicable trust are applied to repay principal of the trust's asset-backed securities rather than being available on a revolving basis to fund the origination activities of our business. The occurrence of an early amortization event also would limit or terminate our ability to issue future series out of the trust in which the early amortization event occurred. No early amortization event has occurred with respect to any of the securitized financings in SYNCT, SFT or SYNIT.

The following table summarizes for each of our trusts the three-month rolling average excess spread at June 30, 2025.

---

| | | | |
|:---|:---|:---|:---|
| | **Note Principal Balance<br>($ in millions)** | **# of Series<br>Outstanding** | **Three-Month Rolling**<br>**Average Excess**<br>**Spread**<sup>(1)</sup> |
| SYNCT | $1650 | 3 | ~ 15.9% to 16.6% |
| SFT | $1275 | 5 | 12.7% |
| SYNIT | $5425 | 1 | 15.2% |

---

______________________

(1)Represents the excess spread (generally calculated as interest income collected from the applicable pool of loan receivables less applicable net charge-offs, interest expense and servicing costs, divided by the aggregate principal amount of loan receivables in the applicable pool) for SFT or, in the case of SYNCT, a range of the excess spreads relating to the particular series issued within such trust or, in the case of SYNIT, the excess spread relating to the one outstanding series issued within such trust, in all cases omitting any series that have not been outstanding for at least three full monthly periods and calculated in accordance with the applicable trust or series documentation, for the three securitization monthly periods ended June 30, 2025.

------

***Senior and Subordinated Unsecured Notes***

During the six months ended June 30, 2025, we made repayments totaling $750 million of senior unsecured notes issued by Synchrony Financial.

The following table provides a summary of our outstanding senior and subordinated unsecured notes at June 30, 2025, which includes $800 million of senior unsecured notes issued by Synchrony Financial in March 2025.

---

| | | | |
|:---|:---|:---|:---|
| **Issuance Date** | **Interest Rate**<sup>(1)</sup> | **Maturity** | **Principal Amount Outstanding**<sup>(2)</sup> |
| *($ in millions)* |  |  |  |
| **Fixed rate senior unsecured notes:** |  |  |  |
| &nbsp;&nbsp;&nbsp;*Synchrony Financial* |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;July 2015<sup>(3)</sup> | &nbsp;&nbsp;4.500% | July 2025 | 1000 |
| &nbsp;&nbsp;&nbsp;&nbsp;August 2016 | &nbsp;&nbsp;3.700% | August 2026 | 500 |
| &nbsp;&nbsp;&nbsp;&nbsp;December 2017 | &nbsp;&nbsp;3.950% | December 2027 | 1000 |
| &nbsp;&nbsp;&nbsp;&nbsp;March 2019 | &nbsp;&nbsp;5.150% | March 2029 | 650 |
| &nbsp;&nbsp;&nbsp;&nbsp;October 2021 | 2.875% | October 2031 | 750 |
| &nbsp;&nbsp;&nbsp;*Synchrony Bank* |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;August 2022 | 5.400% | August 2025 | 900 |
| &nbsp;&nbsp;&nbsp;&nbsp;August 2022 | 5.625% | August 2027 | 600 |
| **Fixed to floating rate senior unsecured notes:** |  |  |  |
| &nbsp;&nbsp;&nbsp;*Synchrony Financial* |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;August 2024 | 5.935%<sup>(4)</sup> | August 2030 | 750 |
| &nbsp;&nbsp;&nbsp;&nbsp;March 2025 | 5.450%<sup>(5)</sup> | March 2031 | 800 |
| **Fixed rate subordinated unsecured notes:** |  |  |  |
| &nbsp;&nbsp;&nbsp;*Synchrony Financial* |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;February 2023 | 7.250% | February 2033 | 750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total fixed rate and fixed to floating rate senior and subordinated unsecured notes** |  |  | $7700 |

---

______________________

(1)Weighted average interest rate of all senior and subordinated unsecured notes at June 30, 2025 was 4.97%.

(2)The amounts shown exclude unamortized debt discounts, premiums and issuance costs.

(3)Principal amount of $1.0 billion repaid in July 2025.

(4)Interest rate fixed through August 1, 2029; resets August 2, 2029 to floating rate based on compounded Secured Overnight Financing Rate ("SOFR") plus 213 basis points.

(5)Interest rate fixed through March 6, 2030; resets March 7, 2030 to floating rate based on compounded Secured Overnight Financing Rate ("SOFR") plus 168 basis points.

***Short-Term Borrowings***

Except as described above, there were no material short-term borrowings for the periods presented.

**Covenants**

The indentures pursuant to which our senior and subordinated unsecured notes have been issued include various covenants. If we do not satisfy any of these covenants, the maturity of amounts outstanding thereunder may be accelerated and become payable. We were in compliance with all of these covenants at June 30, 2025.

At June 30, 2025, we were not in default under any of our credit facilities.

------

**Credit Ratings**

Our borrowing costs and capacity in certain funding markets, including securitizations and senior and subordinated debt, may be affected by the credit ratings of the Company, the Bank and the ratings of our asset-backed securities.

The table below reflects our current credit ratings and outlooks:

---

| | | |
|:---|:---|:---|
| | **S&P** | **Fitch Ratings** |
| **Synchrony Financial** | | |
| &nbsp;&nbsp;&nbsp;Senior unsecured debt | BBB- | BBB |
| &nbsp;&nbsp;&nbsp;Subordinated unsecured debt | BB+ | BBB- |
| &nbsp;&nbsp;&nbsp;Preferred stock | BB- | BB- |
| &nbsp;&nbsp;&nbsp;Outlook for Synchrony Financial | Stable | Stable |
| **Synchrony Bank** | | |
| &nbsp;&nbsp;&nbsp;Senior unsecured debt | BBB | BBB |
| &nbsp;&nbsp;&nbsp;Outlook for Synchrony Bank | Stable | Stable |

---

In addition, certain of the asset-backed securities issued by SYNIT are rated by Fitch, S&P and/or Moody's. A credit rating is not a recommendation to buy, sell or hold securities, may be subject to revision or withdrawal at any time by the assigning rating organization, and each rating should be evaluated independently of any other rating. Downgrades in these credit ratings could materially increase the cost of our funding from, and restrict our access to, the capital markets.

**Liquidity**

**____________________________________________________________________________________________**

We seek to ensure that we have adequate liquidity to sustain business operations, fund asset growth, satisfy debt obligations and to meet regulatory expectations under normal and stress conditions.

We maintain policies outlining the overall framework and general principles for managing liquidity risk across our business, which is the responsibility of our Asset and Liability Management Committee, a management committee under the oversight of the Risk Committee of our Board of Directors. We employ a variety of metrics to monitor and manage liquidity. We perform regular liquidity stress testing and contingency planning as part of our liquidity management process. We evaluate a range of stress scenarios including Company specific and systemic events that could impact funding sources and our ability to meet liquidity needs.

We maintain a liquidity portfolio, which at June 30, 2025 had $21.8 billion of liquid assets, primarily consisting of cash and equivalents, less cash in transit which is not considered to be liquid, compared to $17.2 billion of liquid assets at December 31, 2024. The increase in liquid assets primarily reflects the decrease in loan receivables as compared to December 31, 2024, and the issuances of both senior unsecured debt and securitized debt. We believe our liquidity position at June 30, 2025 remains strong as we continue to operate in a period of uncertain economic conditions and we will continue to closely monitor our liquidity as economic conditions change.

As a general matter, investments included in our liquidity portfolio are expected to be highly liquid, giving us the ability to readily convert them to cash. The level and composition of our liquidity portfolio may fluctuate based upon the level of expected maturities of our funding sources as well as operational requirements and market conditions.

We also have access to several additional sources of liquidity beyond our liquidity portfolio. At June 30, 2025, we had an aggregate of $10.8 billion of available borrowing capacity through the Federal Reserve's discount window. In addition, we had $2.6 billion of undrawn capacity on our securitized financings, subject to customary borrowing conditions, from private lenders under our securitization programs, of which $2.1 billion was committed and $450 million was uncommitted, as well as $500 million of undrawn committed capacity under our unsecured revolving credit facility with private lenders. We also have other unencumbered assets in the Bank available to be used to generate additional liquidity through secured borrowings or asset sales or to be pledged to the Federal Reserve Board for credit at the discount window.

------

We rely significantly on dividends and other distributions and payments from the Bank for liquidity; however, bank regulations, contractual restrictions and other factors limit the amount of dividends and other distributions and payments that the Bank may pay to us. For a discussion of regulatory restrictions related to the Bank's ability to pay dividends, see "*Regulation—Risk Factors Relating to Regulation—We are subject to restrictions that limit our ability to pay dividends and repurchase our common stock; the Bank is subject to restrictions that limit its ability to pay dividends to us, which could limit our ability to pay dividends, repurchase our common stock or make payments on our indebtedness,*" "*Regulation—Regulation Relating to Our Business—Savings Association Regulation—Dividends and Stock Repurchases*" and *—Liquidity," and Regulation—Savings and Loan Holding Company Regulation—Liquidity"* in our 2024 Form 10-K.

**Capital**

**____________________________________________________________________________________________**

Our primary sources of capital have been earnings generated by our business and existing equity capital. We seek to manage capital to a level and composition sufficient to support the risks of our business, meet regulatory requirements, adhere to rating agency targets and support future business growth. The level, composition and utilization of capital are influenced by changes in the economic environment, strategic initiatives and legislative and regulatory developments. Within these constraints, we are focused on deploying capital in a manner that will provide attractive returns to our stockholders.

We are subject to the Federal Reserve Board's formal capital plan submission requirements and submitted our 2025 capital plan to the Federal Reserve Board. We are also now subject to supervisory stress tests on a biennial basis, in even calendar years, and currently expect that the 2026 supervisory stress test is the first stress test in which we will be required to participate.

**Dividend and Share Repurchases**

---

| | | | |
|:---|:---|:---|:---|
| **Common Stock Cash Dividends Declared** | **Month of Payment** | **Amount per Common Share** | **Amount** |
| *Three months ended ($ in millions, except per share data)* |  |  |  |
| March 31, 2025 | February 2025 | $0.25 | $97 |
| June 30, 2025 | May 2025 | 0.30 | 114 |
| **Total dividends declared** |  | $0.55 | $211 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Series A** | **Series A** | **Series B** | **Series B** |
|<br>**Preferred Stock Cash Dividends Declared** |<br>**Month of Payment** | **Amount per Preferred Share** | **Amount** | **Amount per Preferred Share** | **Amount** |
| *Three months ended ($ in millions, except per share data)* | *Three months ended ($ in millions, except per share data)* | *Three months ended ($ in millions, except per share data)* |  |  |  |
| March 31, 2025 | February 2025 | $14.06 | $11 | $20.63 | $10 |
| June 30, 2025 | May 2025 | $14.06 | $10 | 20.63 | 11 |
| **Total dividends declared** |  | $28.12 | $21 | $41.26 | $21 |

---

The declaration and payment of future dividends to holders of our common and preferred stock will be at the discretion of the Board and will depend on many factors. In addition, subject to approval from the Board, we have the ability to issue further series of preferred stock, up to a maximum of 300 million shares authorized for issuance.

For a discussion of regulatory and other restrictions on our ability to pay dividends and repurchase stock, see "*Regulation—Risk Factors Relating to Regulation—We are subject to restrictions that limit our ability to pay dividends and repurchase our common stock; the Bank is subject to restrictions that limit its ability to pay dividends to us, which could limit our ability to pay dividends, repurchase our common stock or make payments on our indebtedness*" in our 2024 Form 10-K.

------

---

| | | |
|:---|:---|:---|
| **Common Shares Repurchased Under Publicly Announced Programs** | **Total Number of Shares <br>Purchased** | **Dollar Value of Shares <br>Purchased** |
| *Three months ended ($ and shares in millions)* |  |  |
| March 31, 2025 | 9.8 | $600 |
| June 30, 2025 | 8.8 | 500 |
| **Total** | 18.6 | $1100 |

---

During the six months ended June 30, 2025, we repurchased $1.1 billion of common stock as part of our share repurchase program. In April 2025, we announced that the Board of Directors approved a share repurchase program of up to $2.5 billion through June 30, 2026 (the "2025 plan"). At June 30, 2025, the Company had a total remaining share repurchase authorization of $2.0 billion under the 2025 plan. Repurchases under this program are subject to market conditions and other factors, including legal and regulatory restrictions and required approvals, if any.

**Regulatory Capital Requirements - Synchrony Financial**

As a savings and loan holding company, we are required to maintain minimum capital ratios, under the applicable U.S. Basel III capital rules. For more information, see "*Regulation—Savings and Loan Holding Company Regulation*" in our 2024 Form 10-K.

For Synchrony Financial to be a well-capitalized savings and loan holding company, Synchrony Bank must be well-capitalized and Synchrony Financial must not be subject to any written agreement, order, capital directive, or prompt corrective action directive issued by the Federal Reserve Board to meet and maintain a specific capital level for any capital measure. At June 30, 2025, Synchrony Financial met all the requirements to be deemed well-capitalized.

The following table sets forth the composition of our capital ratios for the Company calculated under the Basel III Standardized Approach rules at June 30, 2025 and December 31, 2024, respectively.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Basel III** | **Basel III** | **Basel III** | **Basel III** |
| | **At June 30, 2025** | **At June 30, 2025** | **At December 31, 2024** | **At December 31, 2024** |
| *($ in millions)* | **Amount** | **Ratio**<sup>(1)</sup> | **Amount** | **Ratio**<sup>(1)</sup> |
| Total risk-based capital | $17153 | 16.9% | $17407 | 16.5% |
| Tier 1 risk-based capital | $15025 | 14.8% | $15239 | 14.5% |
| Tier 1 leverage | $15025 | 12.7% | $15239 | 12.9% |
| Common equity Tier 1 capital | $13803 | 13.6% | $14017 | 13.3% |
| Risk-weighted assets | $101716 |  | $105417 |  |

---

______________________

(1)Tier 1 leverage ratio represents total Tier 1 capital as a percentage of total average assets, after certain adjustments. All other ratios presented above represent the applicable capital measure as a percentage of risk-weighted assets.

The Company elected to adopt the option provided by the interim final rule issued by joint federal bank regulatory agencies, which largely delayed the effects of CECL on our regulatory capital. The effects were phased-in over a three-year transitional period through 2024, collectively the "CECL regulatory capital transition adjustment". The effects of CECL on our regulatory capital were fully phased-in beginning in the first quarter of 2025. For more information, see "*Capital—Regulatory Capital Requirements - Synchrony Financial*" in our 2024 Form 10-K.

Capital amounts and ratios in the above table reflect the applicable CECL regulatory capital transition adjustment at December 31, 2024. The increase in our common equity Tier 1 capital ratio compared to December 31, 2024 was primarily due to a reduction in risk-weighted assets related to the decrease in loan receivables during the six months ended June 30, 2025 and the retention of net earnings during the same period, partially offset by the final phase-in of the CECL regulatory capital transition adjustment.

------

**Regulatory Capital Requirements - Synchrony Bank**

At June 30, 2025 and December 31, 2024, the Bank met all applicable requirements to be deemed well-capitalized pursuant to the Office of the Comptroller of the Currency of the U.S. Treasury (the "OCC") regulations and for purposes of the Federal Deposit Insurance Act. The following table sets forth the composition of the Bank's capital ratios calculated under the Basel III Standardized Approach rules at June 30, 2025 and December 31, 2024, and also reflects the applicable CECL regulatory capital transition adjustment at December 31, 2024.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **At June 30, 2025** | **At June 30, 2025** | **At December 31, 2024** | **At December 31, 2024** | **Minimum to be Well-Capitalized under Prompt Corrective Action Provisions** |
| *($ in millions)* | **Amount** | **Ratio** | **Amount** | **Ratio** | **Ratio** |
| Total risk-based capital | $15928 | 16.4% | $15916 | 15.8% | 10.0% |
| Tier 1 risk-based capital | $13854 | 14.3% | $13805 | 13.7% | 8.0% |
| Tier 1 leverage | $13854 | 12.3% | $13805 | 12.4% | 5.0% |
| Common equity Tier 1 capital | $13854 | 14.3% | $13805 | 13.7% | 6.5% |

---

Failure to meet minimum capital requirements can result in the initiation of certain mandatory and possibly additional discretionary actions by regulators that, if undertaken, could limit our business activities and have a material adverse effect on our business, results of operations and financial condition. See "*Regulation—Risk Factors Relating to Regulation—Failure by Synchrony and the Bank to meet applicable capital adequacy and liquidity requirements could have a material adverse effect on us*" in our 2024 Form 10-K.

**Off-Balance Sheet Arrangements and Unfunded Lending Commitments**

**____________________________________________________________________________________________**

We do not have any material off-balance sheet arrangements, including guarantees of third-party obligations. Guarantees are contracts or indemnification agreements that contingently require us to make a guaranteed payment or perform an obligation to a third-party based on certain trigger events. At June 30, 2025, we had not recorded any contingent liabilities in our Condensed Consolidated Statements of Financial Position related to any guarantees. See Note 6 - *Variable Interest Entities* to our condensed consolidated financial statements for more information on our investment commitments for unconsolidated variable interest entities.

We extend credit, primarily arising from agreements with customers for unused lines of credit on our credit cards, in the ordinary course of business. Each unused credit card line is unconditionally cancellable by us. See Note 5 - *Loan Receivables and Allowance for Credit Losses* to our condensed consolidated financial statements for more information on our unfunded lending commitments.

------

**Critical Accounting Estimates**

**____________________________________________________________________________________________**

In preparing our condensed consolidated financial statements, we have identified certain accounting estimates and assumptions that we consider to be the most critical to an understanding of our financial statements because they involve significant judgments and uncertainties. The critical accounting estimates we have identified relate to allowance for credit losses and fair value measurements. These estimates reflect our best judgment about current, and for some estimates future, economic and market conditions and their effects based on information available as of the date of these financial statements. If these conditions change from those expected, it is reasonably possible that these judgments and estimates could change, which may result in incremental losses on loan receivables, or material changes to our Condensed Consolidated Statements of Financial Position, among other effects. See below and "*Management's Discussion and Analysis—Critical Accounting Estimates*" in our 2024 Form 10-K, for a detailed discussion of these critical accounting estimates.

**Allowance for Credit Losses**

***Change in methodology for Allowance for Credit Losses***

At June 30, 2025, our Allowance for Credit Losses reflects changes we made during the three months ended March 31, 2025 to our methodology related to the modeling of loss projections attributable to existing loan balances and the reversion to historical mean. Our updated loss forecasting methodology utilizes a statistical, account-level model that analyzes probability of default and exposure at default for our loan receivables, as compared to our prior methodology which utilized an enhanced migration analysis to estimate credit losses. Our reversion methodology, which continues to be applied over a 6-month period, also changed from the prior weighted approach used since the adoption of CECL to apply a straight-line methodology. These changes in methodology were made prospectively to enhance our expected credit loss estimation capabilities and did not have a material effect on our Allowance for Credit Losses in the period of implementation.

For periods presented prior to March 31, 2025, the Allowance for Credit Losses reflects the methodology utilized prior to these changes. See our 2024 Form 10-K for additional information on the prior methodology for our Allowance for Credit Losses, and see below for additional information on the updated methodology reflected in the Allowance for Credit Losses at June 30, 2025.

***Allowance for Credit Losses***

Our Allowance for Credit Losses represents our best estimate of expected credit losses for the life of the loan balance as of the period end date. Expected credit loss estimates involve modeling loss projections attributable to existing loan balances, considering historical experience, current conditions and future expectations for pools of loans with similar risk characteristics, such as retailer, performance and credit attributes, over the reasonable and supportable forecast period and considers historical loss information beyond the reasonable and supportable period.

We use a probability of default and exposure at default model to estimate the expected loan loss, which considers uncollectible principal, interest and fees reflected in the loan receivables, segmented into pools of loans with similar risk characteristics, as well as individual credit characteristics for each account. Our probability of default estimates the likelihood an account will be written off and the exposure at default estimates the balance of an account at the time of write-off. The model considers a macroeconomic forecast, with unemployment and certain income measures as primary variables. We also perform a qualitative assessment in addition to model estimates and apply qualitative adjustments as necessary.

Our estimation process includes analysis of historical data, and there is a significant amount of judgment applied in selecting inputs and analyzing the results produced by the model to determine the Allowance for Credit Losses. Key factors that impact the accuracy of our loss forecast estimates include the models and methodology utilized, credit strategy and trends, and consideration of material changes in our loan portfolio such as changes in growth and portfolio mix.

------

Our estimate of expected credit losses utilizes a reasonable and supportable forecast period of 12 months, consistent with the forecast period utilized since adoption of CECL. The reasonable and supportable forecast period is determined primarily based upon an assessment of the current economic outlook, including our ability to use available data to accurately forecast losses over time. Beyond the reasonable and supportable forecast period, we revert to historical loss information at the loan receivables segment level over a 6-month period on a straight-line basis and utilize historical loss information thereafter for the remaining life of the portfolio. The historical loss information is derived from a combination of recessionary and non-recessionary performance periods, weighted by the estimated time span of each period. Additionally, the estimate of expected credit losses includes expected recoveries of amounts previously charged-off and expected to be charged-off.

The life of a credit card loan receivable is dependent upon the allocation of payments received, as well as a variety of other factors, including the principal balance, promotional terms, interest charges and fees and overall consumer credit profile and usage pattern. To determine the expected credit losses for credit card loan receivables as of the measurement date our estimate considers the payments attributable to the measurement date balance. To do so, we utilize an approach which implicitly considers total expected future payments and applies appropriate allocations to reduce those payments in order to estimate losses pertaining to measurement date loan receivables. Based on our payments analyses, we also ensure that expected future payments from an account do not exceed the measurement date balance.

Further, when historical experience is not available for new portfolios, while we accumulate experience, we may utilize our experience with the most closely analogous products and segments in our portfolio. The underlying assumptions, estimates and assessments we use to provide for losses are updated periodically to reflect our view of current and forecasted conditions and are subject to the regulatory examination process, which can result in changes to our assumptions. Changes in such estimates can significantly affect the allowance and provision for credit losses. It is possible that we will experience credit losses that are different from our current estimates.

------

**Regulation and Supervision**

**____________________________________________________________________________________________**

Our business, including our relationships with our customers, is subject to regulation, supervision and examination under U.S. federal, state and foreign laws and regulations. These laws and regulations cover all aspects of our business, including lending and collection practices, treatment of our customers, safeguarding deposits, customer privacy and information security, capital structure, liquidity, dividends and other capital distributions, transactions with affiliates, and conduct and qualifications of personnel. Such laws and regulations directly and indirectly affect key drivers of our profitability, including, for example, capital and liquidity, product offerings, risk management, and costs of compliance.

As a savings and loan holding company and a financial holding company, Synchrony is subject to regulation, supervision and examination by the Federal Reserve Board. As a large provider of consumer financial services, we are also subject to regulation, supervision and examination by the CFPB.

The Bank is a federally chartered savings association. As such, the Bank is subject to regulation, supervision and examination by the OCC, which is its primary regulator, and by the CFPB. In addition, the Bank, as an insured depository institution, is supervised by the FDIC.

On October 24, 2023, the Federal Reserve, FDIC, and OCC issued a final rule revising their framework for evaluating banks' records of community reinvestment under the Community Reinvestment Act ("CRA"). On March 28, 2025, these bank regulatory agencies announced their intent to issue a proposal to rescind the October 2023 final rule and reinstate the CRA framework that existed prior to the October 2023 final rule. The Bank received a rating of "Outstanding" in its most recent performance evaluation, which was conducted using the CRA framework that existed prior to the October 2023 final rule.

On March 5, 2024, the CFPB released a final rule amending its regulations that implement the Truth in Lending Act to lower the safe harbor dollar amount for credit card late fees from the prior $30 (adjusted to $41 for each subsequent late payment within the next six billing cycles) to $8 and to eliminate the automatic annual inflation adjustment to such safe harbor dollar amount. The final rule had an original effective date of May 14, 2024. Industry organizations challenged the final rule in court, and on May 10, 2024, the United States District Court for the Northern District of Texas granted an injunction and stay of the final rule. On April 14, 2025, the CFPB filed a joint motion with the plaintiff industry organizations in the litigation asking the court to vacate the final rule and dismiss the case. On April 15, 2025, the court granted this motion. As such, the final rule has been vacated.

On September 17, 2024, the OCC finalized a new Policy Statement Regarding Statutory Factors Under the Bank Merger Act (the "Policy Statement"), which updated the factors the OCC would apply in evaluating a proposed bank merger transaction. The Policy Statement could have potentially made it more difficult and/or costly for us to obtain OCC approval for an acquisition or otherwise resulted in more onerous conditions in approval orders than the OCC had previously imposed. On May 8, 2025, the OCC rescinded the Policy Statement.

On October 22, 2024, the CFPB issued a final rule to implement Section 1033 of the Dodd-Frank Act. Under the final rule, financial institutions such as the Bank that offer credit cards or consumer deposit accounts would be required, upon request, to make available to a consumer or third party authorized by the consumer certain information the Bank has concerning a consumer financial product or service covered by the rule, such as a credit card or a deposit account. Industry organizations challenged the final rule in court. On May 30, 2025, the CFPB filed a motion for summary judgment in the litigation, in which the CFPB stated that it had concluded that the final rule exceeded the agency's statutory authority. As a result, the CFPB requested that the court grant the plaintiffs' motion for summary judgment and vacate the final rule. The district court has not yet ruled on the CFPB's motion.

See "*Regulation—Regulation Relating to Our Business*" in our 2024 Form 10-K for additional information on regulations that apply to us, and "*—Capital*" above, for discussion of the impact of regulations and supervision on our capital and liquidity, including our ability to pay dividends and repurchase stock.

------

**INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**____________________________________________________________________________________________**

---

| | |
|:---|:---|
| | **Page** |
| <u>[CONDENSED CONSOLIDATED FINANCIAL STATEMENTS](#i65ebfc98b75047a8b975220340389e60_67)</u> |  |
| <u>[Condensed Consolidated Statements of Earnings](#i65ebfc98b75047a8b975220340389e60_67)</u> | <u>[36](#i65ebfc98b75047a8b975220340389e60_67)</u> |
| <u>[Condensed Consolidated Statements of Comprehensive Income](#i65ebfc98b75047a8b975220340389e60_70)</u> | <u>[37](#i65ebfc98b75047a8b975220340389e60_70)</u> |
| <u>[Condensed Consolidated Statements of Financial Position](#i65ebfc98b75047a8b975220340389e60_73)</u> | <u>[38](#i65ebfc98b75047a8b975220340389e60_73)</u> |
| <u>[Condensed Consolidated Statements of Changes in Equity](#i65ebfc98b75047a8b975220340389e60_76)</u> | <u>[39](#i65ebfc98b75047a8b975220340389e60_76)</u> |
| <u>[Condensed Consolidated Statements of Cash Flows](#i65ebfc98b75047a8b975220340389e60_79)</u> | <u>[41](#i65ebfc98b75047a8b975220340389e60_79)</u> |
| <u>[NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS](#i65ebfc98b75047a8b975220340389e60_82)</u> |  |
| <u>[Note 1. Business Description](#i65ebfc98b75047a8b975220340389e60_85)</u> | <u>[42](#i65ebfc98b75047a8b975220340389e60_85)</u> |
| <u>[Note 2. Basis of Presentation and Summary Significant Accounting Policies](#i65ebfc98b75047a8b975220340389e60_88)</u> | <u>[42](#i65ebfc98b75047a8b975220340389e60_88)</u> |
| <u>[Note 3. Acquisitions and Dispositions](#i65ebfc98b75047a8b975220340389e60_91)</u> | <u>[45](#i65ebfc98b75047a8b975220340389e60_91)</u> |
| <u>[Note 4. Debt Securities](#i65ebfc98b75047a8b975220340389e60_94)</u> | <u>[45](#i65ebfc98b75047a8b975220340389e60_94)</u> |
| <u>[Note 5. Loan Receivables and Allowance for Credit Losses](#i65ebfc98b75047a8b975220340389e60_97)</u> | <u>[47](#i65ebfc98b75047a8b975220340389e60_97)</u> |
| <u>[Note 6. Variable Interest Entities](#i65ebfc98b75047a8b975220340389e60_103)</u> | <u>[53](#i65ebfc98b75047a8b975220340389e60_103)</u> |
| <u>[Note 7. Intangible Assets](#i65ebfc98b75047a8b975220340389e60_112)</u> | <u>[55](#i65ebfc98b75047a8b975220340389e60_112)</u> |
| <u>[Note 8. Deposits](#i65ebfc98b75047a8b975220340389e60_118)</u> | <u>[55](#i65ebfc98b75047a8b975220340389e60_118)</u> |
| <u>[Note 9. Borrowings](#i65ebfc98b75047a8b975220340389e60_121)</u> | <u>[57](#i65ebfc98b75047a8b975220340389e60_121)</u> |
| <u>[Note 10. Fair Value Measurements](#i65ebfc98b75047a8b975220340389e60_124)</u> | <u>[58](#i65ebfc98b75047a8b975220340389e60_124)</u> |
| <u>[Note 11. Regulatory and Capital Adequacy](#i65ebfc98b75047a8b975220340389e60_130)</u> | <u>[60](#i65ebfc98b75047a8b975220340389e60_130)</u> |
| <u>[Note 12. Earnings Per Share](#i65ebfc98b75047a8b975220340389e60_133)</u> | <u>[62](#i65ebfc98b75047a8b975220340389e60_133)</u> |
| <u>[Note 13. Income Taxes](#i65ebfc98b75047a8b975220340389e60_145)</u> | <u>[62](#i65ebfc98b75047a8b975220340389e60_145)</u> |
| <u>[Note 14. Segment Reporting](#i65ebfc98b75047a8b975220340389e60_148)</u> | <u>[62](#i65ebfc98b75047a8b975220340389e60_148)</u> |
| <u>[Note 15. Legal Proceedings and Regulatory Matters](#i65ebfc98b75047a8b975220340389e60_154)</u> | <u>[64](#i65ebfc98b75047a8b975220340389e60_154)</u> |

---

------

**ITEM 1. FINANCIAL STATEMENTS**

**Synchrony Financial and subsidiaries**

**Condensed Consolidated Statements of Earnings (Unaudited)**

**____________________________________________________________________________________________**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions, except per share data)* | **2025** | **2024** | **2025** | **2024** |
| **Interest income:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and fees on loans (Note 5) | $5328 | $5301 | $10640 | $10594 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest on cash and debt securities | 258 | 281 | 496 | 556 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest income | 5586 | 5582 | 11136 | 11150 |
| **Interest expense:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest on deposits | 855 | 967 | 1737 | 1921 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest on borrowings of consolidated securitization entities | 104 | 110 | 208 | 215 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest on senior and subordinated unsecured notes | 106 | 100 | 206 | 204 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest expense | 1065 | 1177 | 2151 | 2340 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net interest income | 4521 | 4405 | 8985 | 8810 |
| Retailer share arrangements | (992) | (810) | (1887) | (1574) |
| Provision for credit losses (Note 5) | 1146 | 1691 | 2637 | 3575 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net interest income, after retailer share arrangements and provision for credit losses | 2383 | 1904 | 4461 | 3661 |
| **Other income:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interchange revenue | 268 | 263 | 506 | 504 |
| &nbsp;&nbsp;&nbsp;&nbsp;Protection product revenue | 144 | 125 | 291 | 266 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loyalty programs | (360) | (346) | (671) | (665) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other (Note 3) | 66 | 75 | 141 | 1169 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other income | 118 | 117 | 267 | 1274 |
| **Other expense:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee costs | 509 | 434 | 1015 | 930 |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional fees | 236 | 236 | 453 | 456 |
| &nbsp;&nbsp;&nbsp;&nbsp;Marketing and business development | 127 | 129 | 243 | 254 |
| &nbsp;&nbsp;&nbsp;&nbsp;Information processing | 215 | 207 | 434 | 393 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 158 | 171 | 343 | 350 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense | 1245 | 1177 | 2488 | 2383 |
| **Earnings before provision for income taxes** | 1256 | 844 | 2240 | 2552 |
| Provision for income taxes (Note 13) | 289 | 201 | 516 | 616 |
| **Net earnings** | $967 | $643 | $1724 | $1936 |
| **Net earnings available to common stockholders** | $946 | $624 | $1682 | $1906 |
| Earnings per share (Note 12) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $2.51 | $1.56 | $4.42 | $4.74 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $2.50 | $1.55 | $4.38 | $4.70 |

---

See accompanying notes to condensed consolidated financial statements.

------

**Synchrony Financial and subsidiaries**

**Condensed Consolidated Statements of Comprehensive Income (Unaudited)**

**____________________________________________________________________________________________**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Net earnings | $967 | $643 | $1724 | $1936 |
| Other comprehensive income (loss) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt securities | 3 |  | 11 | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Currency translation adjustments | 5 | (4) | 4 | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee benefit plans and other |  |  | (1) |  |
| Other comprehensive income (loss) | 8 | (4) | 14 | (5) |
| Comprehensive income | $975 | $639 | $1738 | $1931 |

---

Amounts presented net of taxes.

See accompanying notes to condensed consolidated financial statements.

------

**Synchrony Financial and subsidiaries**

**Condensed Consolidated Statements of Financial Position (Unaudited)**

**____________________________________________________________________________________________**

---

| | | |
|:---|:---|:---|
| *($ in millions)* | **At June 30, 2025** | **At December 31, 2024** |
| **Assets** |  |  |
| Cash and equivalents | $19457 | $14711 |
| Debt securities (Note 4) | 2905 | 3079 |
| Loan receivables: (Notes 5 and 6) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Unsecuritized loans held for investment | 78566 | 83382 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted loans of consolidated securitization entities | 21210 | 21339 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total loan receivables | 99776 | 104721 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Allowance for credit losses | (10564) | (10929) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loan receivables, net | 89212 | 93792 |
| Loan receivables held for sale (Note 5) | 191 |  |
| Goodwill | 1274 | 1274 |
| Intangible assets, net (Note 7) | 862 | 854 |
| Other assets | 6604 | 5753 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $120505 | $119463 |
| **Liabilities and Equity** |  |  |
| Deposits: (Note 8) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest-bearing deposit accounts | $81857 | $81664 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-interest-bearing deposit accounts | 405 | 398 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deposits | 82262 | 82062 |
| Borrowings: (Notes 6 and 9) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Borrowings of consolidated securitization entities | 8340 | 7842 |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior and subordinated unsecured notes | 7669 | 7620 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total borrowings | 16009 | 15462 |
| Accrued expenses and other liabilities | 5282 | 5359 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $103553 | $102883 |
| Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, par value $0.001 per share; 1,250,000 shares authorized, issued and outstanding; and aggregate liquidation preference of $1,250 at both June 30, 2025 and December 31, 2024 | $1222 | $1222 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, par value $0.001 per share; 4,000,000,000 shares authorized; 833,984,684 shares issued at both June 30, 2025 and December 31, 2024; 371,942,844 and 388,261,077 shares outstanding at June 30, 2025 and December 31, 2024, respectively | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 9836 | 9853 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 23036 | 21635 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income (loss): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debt securities | (12) | (23) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Currency translation adjustments | (40) | (44) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employee benefit plans and other | 7 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, at cost; 462,041,840 and 445,723,607 shares at June 30, 2025 and December 31, 2024, respectively | (17098) | (16072) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | 16952 | 16580 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and equity | $120505 | $119463 |

---

See accompanying notes to condensed consolidated financial statements.

------

**Synchrony Financial and subsidiaries**

**Condensed Consolidated Statements of Changes in Equity (Unaudited)**

**____________________________________________________________________________________________**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock** | **Preferred Stock** | **Common Stock** | **Common Stock** | | | | | |
| ($ in millions, <br>shares in thousands) | **Shares Issued** | **Amount** | **Shares Issued** | **Amount** | **Additional Paid-in Capital** | **Retained Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Treasury Stock** | **Total Equity** |
| Balance at <br>January 1, 2024 | 750 | $734 | 833985 | $1 | $9775 | $18662 | $(68) | $(15201) | $13903 |
| Net earnings |  |  |  |  |  | 1293 |  |  | 1293 |
| Other comprehensive income |  |  |  |  |  |  | (1) |  | (1) |
| Issuance of preferred stock | 500 | 488 |  |  |  |  |  |  | 488 |
| Purchases of treasury stock |  |  |  |  |  |  |  | (300) | (300) |
| Stock-based compensation |  |  |  |  | (7) | (52) |  | 71 | 12 |
| Dividends - Series A preferred stock <br>($14.06 per share) |  |  |  |  |  | (11) |  |  | (11) |
| Dividends - common stock <br>($0.25 per share) |  |  |  |  |  | (102) |  |  | (102) |
| Balance at <br>March 31, 2024 | 1250 | $1222 | 833985 | $1 | $9768 | $19790 | $(69) | $(15430) | $15282 |
| Net earnings |  |  |  |  |  | 643 |  |  | 643 |
| Other comprehensive income |  |  |  |  |  |  | (4) |  | (4) |
| Purchases of treasury stock |  |  |  |  |  |  |  | (305) | (305) |
| Stock-based compensation |  |  |  |  | 25 | (4) |  | 22 | 43 |
| Dividends - Series A preferred stock <br>($14.06 per share) |  |  |  |  |  | (10) |  |  | (10) |
| Dividends - Series B preferred stock ($18.79 per share) |  |  |  |  |  | (9) |  |  | (9) |
| Dividends - common stock <br>($0.25 per share) |  |  |  |  |  | (100) |  |  | (100) |
| Balance at <br>June 30, 2024 | 1250 | $1222 | 833985 | $1 | $9793 | $20310 | $(73) | $(15713) | $15540 |

---

------

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock** | **Preferred Stock** | **Common Stock** | **Common Stock** | | | | | |
| *($ in millions, <br>shares in thousands)* | **Shares Issued** | **Amount** | **Shares Issued** | **Amount** | **Additional Paid-in Capital** | **Retained Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Treasury Stock** | **Total Equity** |
| Balance at <br>January 1, 2025 | 1250 | $1222 | 833985 | $1 | $9853 | $21635 | $(59) | $(16072) | $16580 |
| Net earnings |  |  |  |  |  | 757 |  |  | 757 |
| Other comprehensive income |  |  |  |  |  |  | 6 |  | 6 |
| Purchases of treasury stock |  |  |  |  |  |  |  | (605) | (605) |
| Stock-based compensation |  |  |  |  | (49) | (65) |  | 75 | (39) |
| Dividends - Series A preferred stock<br>($14.06 per share) |  |  |  |  |  | (11) |  |  | (11) |
| Dividends - Series B preferred stock ($20.63 per share) |  |  |  |  |  | (10) |  |  | (10) |
| Dividends - common stock <br>($0.25 per share) |  |  |  |  |  | (97) |  |  | (97) |
| Balance at <br>March 31, 2025 | 1250 | $1222 | 833985 | $1 | $9804 | $22209 | $(53) | $(16602) | $16581 |
| Net earnings |  |  |  |  |  | 967 |  |  | 967 |
| Other comprehensive income |  |  |  |  |  |  | 8 |  | 8 |
| Purchases of treasury stock |  |  |  |  |  |  |  | (504) | (504) |
| Stock-based compensation |  |  |  |  | 32 | (5) |  | 8 | 35 |
| Dividends - Series A preferred stock<br>($14.06 per share) |  |  |  |  |  | (10) |  |  | (10) |
| Dividends - Series B preferred stock<br>($20.63 per share) |  |  |  |  |  | (11) |  |  | (11) |
| Dividends - common stock <br>($0.30 per share) |  |  |  |  |  | (114) |  |  | (114) |
| Balance at <br>June 30, 2025 | 1250 | $1222 | 833985 | $1 | $9836 | $23036 | $(45) | $(17098) | $16952 |

---

See accompanying notes to condensed consolidated financial statements.

------

**Synchrony Financial and subsidiaries**

**Condensed Consolidated Statements of Cash Flows (Unaudited)** 

**____________________________________________________________________________________________**

---

| | | |
|:---|:---|:---|
| | **Six months ended June 30,** | **Six months ended June 30,** |
| (*$ in millions*) | **2025** | **2024** |
| **Cash flows - operating activities** |  |  |
| Net earnings | $1724 | $1936 |
| Adjustments to reconcile net earnings to cash provided from operating activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for credit losses | 2637 | 3575 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 31 | (8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 247 | 240 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of business |  | (1069) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All other operating activities | 280 | 208 |
| Changes in operating assets and liabilities, net of effects of acquisitions and dispositions |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in interest and fees receivable | (65) | 209 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in other assets | (9) | (120) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in accrued expenses and other liabilities | (85) | (239) |
| **Cash provided from (used for) operating activities** | 4760 | 4732 |
| **Cash flows - investing activities** |  |  |
| Maturity and sales of debt securities | 1205 | 2196 |
| Purchases of debt securities | (1006) | (1047) |
| Acquisitions, net of cash acquired |  | (1935) |
| Proceeds from sale of business, net of cash and restricted cash sold |  | 491 |
| Net (increase) decrease in loan receivables, including held for sale | 1607 | (1092) |
| All other investing activities | (444) | (322) |
| **Cash provided from (used for) investing activities** | 1362 | (1709) |
| **Cash flows - financing activities** |  |  |
| Borrowings of consolidated securitization entities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of securitized debt | 1495 | 947 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Maturities and repayment of securitized debt | (1000) | (700) |
| Senior and subordinated unsecured notes |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of senior and subordinated unsecured notes | 794 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Maturities and repayment of senior and subordinated unsecured notes | (750) | (600) |
| Proceeds from issuance of preferred stock |  | 488 |
| Dividends paid on preferred stock | (42) | (30) |
| Net increase (decrease) in deposits | 195 | 1938 |
| Purchases of treasury stock | (1109) | (605) |
| Dividends paid on common stock | (211) | (202) |
| All other financing activities | (70) | 1 |
| **Cash provided from (used for) financing activities** | (698) | 1237 |
| **Increase (decrease) in cash and equivalents, including restricted amounts** | 5424 | 4260 |
| Cash and equivalents, including restricted amounts, at beginning of period | 14755 | 14420 |
| Cash and equivalents at end of period: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and equivalents | 19457 | 18632 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash and equivalents included in other assets | 722 | 48 |
| **Total cash and equivalents, including restricted amounts, at end of period** | $20179 | $18680 |

---

See accompanying notes to condensed consolidated financial statements.

------

**Synchrony Financial and subsidiaries**

**Notes to Condensed Consolidated Financial Statements (Unaudited)**

**____________________________________________________________________________________________**

**NOTE 1.&nbsp;&nbsp;&nbsp;&nbsp;BUSINESS DESCRIPTION**

Synchrony Financial (the "Company") provides a range of credit products through financing programs it has established with a diverse group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations and healthcare service providers. We primarily offer private label, Dual Card, co-brand and general purpose credit cards, as well as short- and long-term installment loans, and savings products insured by the Federal Deposit Insurance Corporation ("FDIC") through Synchrony Bank (the "Bank"). We conduct our operations through a single business segment. See Note 14. *Segment Reporting* for additional information.

References to the "Company", "we", "us" and "our" are to Synchrony Financial and its consolidated subsidiaries unless the context otherwise requires.

**NOTE 2.&nbsp;&nbsp;&nbsp;&nbsp;BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES** 

***Basis of Presentation***

The accompanying condensed consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles ("GAAP").

Preparing financial statements in conformity with U.S. GAAP requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions (for example, unemployment, interest rates and market liquidity) which affect reported amounts and related disclosures in our condensed consolidated financial statements. Although our current estimates contemplate current conditions and how we expect them to change in the future, as appropriate, it is reasonably possible that actual conditions could be different than anticipated in those estimates, which could materially affect our results of operations and financial position. Among other effects, such changes could result in incremental losses on loan receivables, future impairments of debt securities, goodwill and intangible assets, increases in reserves for contingencies, establishment of valuation allowances on deferred tax assets and increases in our tax liabilities.

We primarily conduct our business within the United States and substantially all of our revenues are from U.S. customers. The operating activities conducted by our non-U.S. affiliates use the local currency as their functional currency. The effects of translating the financial statements of these non-U.S. affiliates to U.S. dollars are included in equity. Asset and liability accounts are translated at period-end exchange rates, while revenues and expenses are translated at average rates for the respective periods.

*Consolidated Basis of Presentation*

The Company's financial statements have been prepared on a consolidated basis. Under this basis of presentation, our financial statements consolidate all of our subsidiaries – i.e., entities in which we have a controlling financial interest, most often because we hold a majority voting interest. To determine if we hold a controlling financial interest in an entity, we first evaluate if we are required to apply the variable interest entity ("VIE") model to the entity, otherwise the entity is evaluated under the voting interest model. We consolidate certain securitization entities under the VIE model because we have both power to direct and significant economics, primarily because of Synchrony or the Bank's role as servicer. See Note 6. *Variable Interest Entities*.

------

***Interim Period Presentation***

The condensed consolidated financial statements and notes thereto are unaudited. These statements include all adjustments (consisting of normal recurring accruals) that we considered necessary to present a fair statement of our results of operations, financial position and cash flows. The results reported in these condensed consolidated financial statements should not be considered as necessarily indicative of results that may be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with our 2024 annual consolidated financial statements and the related notes in our Annual Report on Form 10-K for the year ended December 31, 2024 (our "2024 Form 10-K").

***New Accounting Standards***

*Recently Issued But Not Yet Adopted Accounting Standards*

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires disclosure of specific categories in the rate reconciliation, as well as additional qualitative information about the reconciliation, and additional disaggregated information about income taxes paid. The Company will adopt this guidance on a retrospective basis on its effective date, which for us is beginning within our December 31, 2025 Form 10-K. Management does not expect this guidance to have a material impact on the Consolidated Financial Statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40). This ASU requires disaggregated information about certain income statement line items in a tabular format in the notes to the financial statements. The Company will adopt this guidance on its effective date, which for us is beginning within our December 31, 2027 Form 10-K, and is currently determining the method of adoption, however, it is not expected to have a material impact on our Consolidated Financial Statements.

***Allowance for Credit Losses***

*Changes in methodology for Allowance for Credit Losses*

At June 30, 2025, our Allowance for Credit Losses reflects changes we made during the three months ended March 31, 2025 to our methodology related to the modeling of loss projections attributable to existing loan balances and the reversion to historical mean. Our updated loss forecasting methodology utilizes a statistical, account-level model that analyzes probability of default and exposure at default for our loan receivables, as compared to our prior methodology which utilized an enhanced migration analysis to estimate credit losses. Our reversion methodology, which continues to be applied over a 6-month period, also changed from the prior weighted approach used since the adoption of CECL to apply a straight-line methodology. These changes in methodology were made prospectively to enhance our expected credit loss estimation capabilities and did not have a material effect on our Allowance for Credit Losses in the period of implementation.

For periods presented prior to March 31, 2025, the Allowance for Credit Losses reflects the methodology utilized prior to these changes. See 2024 Form 10-K for additional information on the prior methodology for our Allowance for Credit Losses, and see below for additional information on the updated methodology reflected in the Allowance for Credit Losses at June 30, 2025.

Losses on loan receivables are estimated and recognized upon origination of the loan, based on expected credit losses for the life of the loan balance as of the period end date. Expected credit loss estimates involve modeling loss projections attributable to existing loan balances, considering historical experience, current conditions and future expectations for pools of loans with similar risk characteristics, such as retailer, performance and credit attributes, over the reasonable and supportable forecast period and considers historical loss information beyond the reasonable and supportable period.

We use a probability of default and exposure at default model to estimate the expected loan loss, which considers uncollectible principal, interest and fees reflected in the loan receivables, segmented into pools of loans with similar risk characteristics, as well as individual credit characteristics for each account. The model considers a macroeconomic forecast, with unemployment and certain income measures as primary variables. We also perform a qualitative assessment in addition to model estimates and apply qualitative adjustments as necessary.

------

We evaluate our Allowance for Credit Losses quarterly. Our estimation process includes analysis of historical data, and there is a significant amount of judgment applied in selecting inputs and analyzing the results produced by the model to determine the Allowance for Credit Losses. Other data utilized in our estimate of expected losses, includes past performance, changes in underwriting policies, bankruptcy activity such as filings and loan volumes and amounts. We also evaluate portfolio risk management techniques applied to various accounts, historical behavior of different account vintages, account seasoning, economic conditions, recent trends in delinquencies and net charge-offs, account collection management including the impact of modifications made to borrowers experiencing financial difficulties, forecasting uncertainties, expectations about the future and a qualitative assessment of the adequacy of the allowance for credit losses. Additionally, the estimate of expected credit losses includes expected recoveries of amounts previously charged-off and expected to be charged-off.

Our credit card loan receivables generally do not have a stated life. The life of a credit card loan receivable is dependent upon the allocation of payments received, as well as a variety of other factors, including the principal balance, promotional terms, interest charges and fees and overall consumer credit profile and usage pattern. We determine the expected credit losses for credit card loan receivables as of the measurement date by using an estimated probability of default and exposure at default model, and other historical analyses, which considers the payments attributable to the measurement date balance. To do so, we utilize an approach which implicitly considers total expected future payments and applies appropriate allocations to reduce those payments in order to estimate losses pertaining to measurement date loan receivables. Based on our payments analyses, we also ensure that expected future payments from an account do not exceed the measurement date balance.

The reasonable and supportable forecast period is determined primarily based upon an assessment of the current economic outlook, including our ability to use available data to accurately forecast losses over time. The reasonable and supportable forecast period used in our estimate of credit losses at June 30, 2025 was 12 months, consistent with the forecast period utilized since adoption of CECL. The Company reassesses the reasonable and supportable forecast period on a quarterly basis. Beyond the reasonable and supportable forecast period, we revert to historical loss information at the loan receivables segment level over a 6-month period on a straight-line basis, and utilize historical loss information thereafter for the remaining life of the portfolio. The historical loss information is derived from a combination of recessionary and non-recessionary performance periods, weighted by the estimated time span of each period. Similar to the reasonable and supportable forecast period, we also reassess the reversion period and historical mean on a quarterly basis, considering any required adjustments for differences in underwriting standards, portfolio mix, and other relevant data shifts over time.

The underlying assumptions, estimates and assessments we use to provide for losses are updated periodically to reflect our view of current and forecasted conditions, and are subject to the regulatory examination process, which can result in changes to our assumptions. Changes in such estimates can significantly affect the allowance and provision for credit losses. It is possible that we will experience credit losses that are different from our current estimates. Consistent with our other assumptions, we also review segmentation to determine whether the segmentation pools remain relevant as risk characteristics change.

Charge-offs are deducted from the allowance for credit losses and are recorded in the period when we judge the principal to be uncollectible, and subsequent recoveries are added to the allowance, generally at the time cash is received on a charged-off account.

Delinquent receivables are those that are 30 days or more past due based on their contractual payments. Non-accrual loan receivables are those on which we have stopped accruing interest. We typically continue to accrue interest until the earlier of the time at which collection of an account becomes doubtful, or in the period the account becomes 180 days past due, with the exception of non-credit card accounts, for which we stop accruing interest in the period that the account becomes 90 days past due.

The same loan receivable may meet more than one of the definitions above. Accordingly, these categories are not mutually exclusive, and it is possible for a particular loan to meet the definitions of a non-accrual loan and a delinquent loan, or be modified to a borrower experiencing financial difficulty, and be included in each of these categories. The categorization of a particular loan also may not necessarily be indicative of the potential for loss.

See Note 2. *Basis of Presentation and Summary of Significant Accounting Policies* to our 2024 annual consolidated financial statements in our 2024 Form 10-K, for additional information on our other significant accounting policies.

------

**NOTE 3.&nbsp;&nbsp;&nbsp;&nbsp;ACQUISITIONS AND DISPOSITIONS** 

***Ally Lending***

On March 1, 2024, we acquired Ally Financial Inc.'s point of sale financing business, ("Ally Lending") for cash consideration of $2.0 billion. This acquisition deepened our presence and reach in the home improvement and health and wellness sectors, including high-growth specialty areas such as roofing, HVAC, and windows, as well as in cosmetic, audiology, and dentistry. The acquisition primarily included loan receivables with an unpaid principal balance of $2.2 billion.

***Pets Best***

In March 2024, we sold our wholly-owned subsidiary, Pets Best Insurance Services, LLC ("Pets Best") to Poodle Holdings, Inc. ("Buyer") for consideration comprising a combination of cash and an equity interest of less than 10% in Independence Pet Holdings, Inc., ("IPH") an affiliate of Buyer. The sale of Pets Best resulted in the recognition of a gain on sale of $1.1 billion or $802 million, net of tax in the three months ended March 31, 2024. The pre-tax gain amount has been recognized within the Other component of Other income in our Condensed Consolidated Statements of Earnings.

The Company's initial equity investment in IPH was recorded in Other assets on our Condensed Consolidated Statements of Financial Position and is accounted for under the equity method of accounting. The investment was recorded at its estimated fair value at the date acquired of $605 million. The change in the carrying value of our equity investment in IPH subsequent to the date acquired was not material.

See Note 3. *Acquisitions and Dispositions* to our 2024 annual consolidated financial statements in our 2024 Form 10-K, for additional information on both the Ally Lending and Pets Best transactions completed in the prior year.

**NOTE 4.&nbsp;&nbsp;&nbsp;&nbsp;DEBT SECURITIES** 

All of our debt securities are classified as available-for-sale and are held to meet our liquidity objectives or to comply with the Community Reinvestment Act ("CRA"). Our debt securities consist of the following:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | | **Gross** | **Gross** | | | **Gross** | **Gross** | |
| | **Amortized** | **unrealized** | **unrealized** | **Estimated** | **Amortized** | **unrealized** | **unrealized** | **Estimated** |
| *($ in millions)* | **cost** | **gains** | **losses** | **fair value** | **cost** | **gains** | **losses** | **fair value** |
| U.S. government and federal agency | $1798 | $7 | $— | $1805 | $1841 | $3 | $— | $1844 |
| State and municipal | 26 |  |  | 26 | 17 |  | (1) | 16 |
| Residential mortgage-backed<sup>(a)</sup> | 310 |  | (27) | 283 | 324 |  | (35) | 289 |
| Asset-backed<sup>(b)</sup> | 778 | 4 |  | 782 | 919 | 4 | (1) | 922 |
| Other | 8 | 1 |  | 9 | 8 |  |  | 8 |
| **Total**<sup>(c)</sup> | $2920 | $12 | $(27) | $2905 | $3109 | $7 | $(37) | $3079 |

---

_______________________

(a)&nbsp;&nbsp;&nbsp;&nbsp;All of our residential mortgage-backed securities have been issued by government-sponsored entities and are collateralized by U.S. mortgages.

(b)&nbsp;&nbsp;&nbsp;&nbsp;Our asset-backed securities are collateralized by credit card and auto loans.

(c)&nbsp;&nbsp;&nbsp;&nbsp;At June 30, 2025 and December 31, 2024, the estimated fair value of debt securities pledged by the Bank as collateral to the Federal Reserve to secure Federal Reserve discount window advances was $451 million and $551 million, respectively.

------

The following table presents the estimated fair values and gross unrealized losses of our available-for-sale debt securities:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **In loss position for** | **In loss position for** | **In loss position for** | **In loss position for** |
| | **Less than 12 months** | **Less than 12 months** | **12 months or more** | **12 months or more** |
| | | **Gross** | | **Gross** |
| | **Estimated** | **unrealized** | **Estimated** | **unrealized** |
| *($ in millions)* | **fair value** | **losses** | **fair value** | **losses** |
| *At June 30, 2025* |  |  |  |  |
| U.S. government and federal agency | $— | $— | $— | $— |
| State and municipal | 9 |  | 6 |  |
| Residential mortgage-backed | 9 |  | 255 | (27) |
| Asset-backed | 58 |  | 4 |  |
| Other |  |  |  |  |
| **Total**<sup>(a)</sup> | $76 | $— | $265 | $(27) |
| *At December 31, 2024* |  |  |  |  |
| U.S. government and federal agency | $199 | $— | $— | $— |
| State and municipal | 12 | (1) | 3 |  |
| Residential mortgage-backed | 5 |  | 279 | (35) |
| Asset-backed | 79 | (1) | 4 |  |
| Other |  |  |  |  |
| **Total**<sup>(a)</sup> | $295 | $(2) | $286 | $(35) |

---

______________________

(a)Consists of 221 and 224 securities in gross unrealized loss positions at June 30, 2025 and December 31, 2024, respectively.

We regularly review debt securities for impairment resulting from credit loss using both qualitative and quantitative criteria, as necessary, based on the composition of the portfolio at period end. Based on our assessment, no material impairments from credit losses were recognized during the period.

We presently do not intend to sell our debt securities that are in an unrealized loss position and believe that it is not more likely than not that we will be required to sell these securities before recovery of our amortized cost.

------

***Contractual Maturities of Investments in Available-for-Sale Debt Securities***

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| *At June 30, 2025 ($ in millions)* | **Due within 1 year** | **Due after 1 year through 5 years** | **Due after 5 years through 10 years** | **Due after 10 years** | **Total** |
| U.S. government and federal agency | $952 | $853 | $— | $— | $1805 |
| State and municipal |  | 3 | 3 | 20 | 26 |
| Residential mortgage-backed |  | 12 | 109 | 162 | 283 |
| Asset-backed | 315 | 467 |  |  | 782 |
| Other |  | 9 |  |  | 9 |
| Total estimated fair value | $1267 | $1344 | $112 | $182 | $2905 |
| Amortized cost | $1265 | $1334 | $118 | $203 | $2920 |
| Weighted average yield<sup>(a)</sup> | 4.6% | 4.4% | 1.8% | 2.7% | 4.2% |

---

______________________

(a)Weighted average yield is calculated based on the amortized cost of each security. In calculating yield, no adjustment has been made with respect to any tax-exempt obligations.

All securities are presented above based upon contractual maturity date, except our asset-backed securities which are allocated based upon expected final payment date. We expect actual maturities to differ from contractual maturities because borrowers have the right to prepay certain obligations.

There were no material realized gains or losses recognized for the six months ended June 30, 2025 and 2024.

Although we generally do not have the intent to sell any specific securities held at June 30, 2025, in the ordinary course of managing our debt securities portfolio, we may sell securities prior to their maturities for a variety of reasons, including diversification, credit quality, yield, liquidity requirements and funding obligations.

**NOTE 5.&nbsp;&nbsp;&nbsp;&nbsp;LOAN RECEIVABLES AND ALLOWANCE FOR CREDIT LOSSES**

---

| | | |
|:---|:---|:---|
| *($ in millions)* | **June 30, 2025** | **December 31, 2024** |
| Credit cards | $92036 | $96818 |
| Consumer installment loans | 5669 | 5971 |
| Commercial credit products | 1980 | 1826 |
| Other | 91 | 106 |
| **Total loan receivables, before allowance for credit losses**<sup>(a)(b)(c)</sup> | $99776 | $104721 |

---

_______________________

(a)Total loan receivables include $21.2 billion and $21.3 billion of restricted loans of consolidated securitization entities at June 30, 2025 and December 31, 2024, respectively. See Note 6. *Variable Interest Entities* for further information.

(b)At June 30, 2025 and December 31, 2024, loan receivables included deferred costs, net of purchase discounts and deferred income of $(156) million and $(212) million, respectively.

(c)At June 30, 2025 and December 31, 2024, $19.9 billion and $20.7 billion, respectively, of loan receivables were pledged by the Bank as collateral to the Federal Reserve to secure Federal Reserve discount window advances.

***Loan Receivables Held for Sale***

During the second quarter of 2025, we entered into an agreement to sell loan receivables associated with one of our retailer program agreements. As a result, at June 30, 2025, these loan receivables are classified as loan receivables held for sale on our Condensed Consolidated Statement of Financial Position. The sale of the portfolio, which is subject to customary closing conditions, is expected to be completed in the fourth quarter of 2025.

------

***Allowance for Credit Losses***<sup>(a)</sup>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| *($ in millions)* | **Balance at <br>April 1, 2025** | **Provision charged to operations**<sup>(b)</sup> | **Gross charge-offs** | **Recoveries** | **Other** | **Balance at <br>June 30, 2025** |
| Credit cards | $10133 | $1077 | $(1674) | $370 | $— | $9906 |
| Consumer installment loans | 584 | 38 | (92) | 15 |  | 545 |
| Commercial credit products | 110 | 32 | (33) | 3 |  | 112 |
| Other | 1 |  |  |  |  | 1 |
| **Total** | $10828 | $1147 | $(1799) | $388 | $— | $10564 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| *($ in millions)* | **Balance at <br>April 1, 2024** | **Provision charged to operations**<sup>(b)</sup> | **Gross charge-offs** | **Recoveries** | **Other** | **Balance at <br>June 30, 2024** |
| Credit cards | $10194 | $1547 | $(1832) | $339 | $7 | $10255 |
| Consumer installment loans | 581 | 113 | (107) | 15 |  | 602 |
| Commercial credit products | 127 | 31 | (37) | 2 |  | 123 |
| Other | 3 |  | (1) |  |  | 2 |
| **Total** | $10905 | $1691 | $(1977) | $356 | $7 | $10982 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| *($ in millions)* | **Balance at <br>January 1, 2025** | **Provision charged to operations**<sup>(b)</sup> | **Gross charge-offs** | **Recoveries** | **Other** | **Balance at <br>June 30, 2025** |
| Credit cards | $10259 | $2413 | $(3496) | $730 | $— | $9906 |
| Consumer installment loans | 542 | 173 | (202) | 32 |  | 545 |
| Commercial credit products | 127 | 48 | (68) | 5 |  | 112 |
| Other | 1 |  |  |  |  | 1 |
| **Total** | $10929 | $2634 | $(3766) | $767 | $— | $10564 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| *($ in millions)* | **Balance at <br>January 1, 2024** | **Provision charged to operations**<sup>(b)</sup> | **Gross charge-offs** | **Recoveries** | **Other**<sup>(c)</sup> | **Balance at <br>June 30, 2024** |
| Credit cards | $10156 | $3055 | $(3593) | $630 | $7 | $10255 |
| Consumer installment loans | 279 | 458 | (197) | 23 | 39 | 602 |
| Commercial credit products | 131 | 6 | (72) | 4 |  | 123 |
| Other | 5 | (2) | (1) |  |  | 2 |
| **Total** | $10571 | $3517 | $(3863) | $657 | $46 | $10982 |

---

_______________________

(a)Excluded from the table above are allowance for credit losses for loan receivables acquired and immediately written off within the period presented.

(b)Provision for credit losses in our Condensed Consolidated Statements of Earnings also includes amounts associated with off-balance sheet credit exposures recorded in Accrued expenses and other liabilities in the Condensed Consolidated Statements of Financial Position.

(c)Primarily represents allowance for credit losses for purchased credit deteriorated assets.

The reasonable and supportable forecast period used in our estimate of credit losses at June 30, 2025 was 12 months, consistent with the forecast period utilized since the adoption of CECL. Beyond the reasonable and supportable forecast period, we revert to historical loss information at the loan receivables segment level over a 6-month period, and utilize historical loss information thereafter for the remaining life of the portfolio.

------

Losses on loan receivables, including those which are modified for borrowers experiencing financial difficulty, are estimated and recognized upon origination of the loan, based on expected credit losses for the life of the loan balance at June 30, 2025. Expected credit loss estimates are developed using both quantitative models and qualitative adjustments, and incorporates a macroeconomic forecast. The current and forecasted economic conditions at the balance sheet date are reflected in our current estimate of expected credit losses, which includes consideration of the decrease in both loan receivables and delinquent balances as a percentage of loan receivables, compared to the prior year period, as well as expectations of the macroeconomic environment. Our allowance for credit losses decreased to $10.6 billion during the six months ended June 30, 2025, primarily reflecting these conditions. See Note 2. *Basis of Presentation and Summary of Significant Accounting Policies* for additional information on our significant accounting policies related to our allowance for credit losses at June 30, 2025, and Note 2. *Basis of Presentation and Summary of Significant Accounting Policies* to our 2024 annual consolidated financial statements within our 2024 Form 10-K, for additional information on our significant accounting policies related to our allowance for credit losses at December 31, 2024.

***Delinquent and Non-accrual Loans***

The following table provides information on our delinquent and non-accrual loan receivables:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| *At June 30, 2025 ($ in millions)* | **30-89 days delinquent** | **90 or more days delinquent** | **Total past due** | **90 or more days delinquent and accruing** | **Total non-accruing** |
| Credit cards | $1960 | $1995 | $3955 | $1995 | $— |
| Consumer installment loans | 117 | 26 | 143 |  | 26 |
| Commercial credit products | 37 | 38 | 75 | 38 |  |
| Total delinquent loans | $2114 | $2059 | $4173 | $2033 | $26 |
| Percentage of total loan receivables | 2.1% | 2.1% | 4.2% | 2.0% | —% |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| *At December 31, 2024 ($ in millions)* | **30-89 days delinquent** | **90 or more days delinquent** | **Total past due** | **90 or more days delinquent and accruing** | **Total non-accruing** |
| Credit cards | $2229 | $2431 | $4660 | $2431 | $— |
| Consumer installment loans | 139 | 39 | 178 |  | 39 |
| Commercial credit products | 45 | 42 | 87 | 42 |  |
| Total delinquent loans | $2413 | $2512 | $4925 | $2473 | $39 |
| Percentage of total loan receivables | 2.3% | 2.4% | 4.7% | 2.4% | —% |

---

***Credit Quality Indicators***

Our loan receivables portfolio includes both secured and unsecured loans. Secured loan receivables are largely comprised of consumer installment loans secured by equipment. Unsecured loan receivables are largely comprised of our open-ended consumer and commercial revolving credit card loans. As part of our credit risk management activities, on an ongoing basis, we assess overall credit quality by reviewing information related to the performance of a customer's account with us, including delinquency information, as well as information from credit bureaus relating to the customer's broader credit performance. We utilize VantageScore credit data and scores to assist in our assessment of credit quality. VantageScore credit data and scores are obtained at origination of the account and are refreshed, at a minimum quarterly, but could be as often as weekly, to assist in predicting customer behavior. We categorize these credit scores into the following three credit score categories: (i) 651 or higher, which are considered the strongest credits; (ii) 591 to 650, considered moderate credit risk; and (iii) 590 or less, which are considered weaker credits. There are certain customer accounts, including for our commercial credit products, for which a VantageScore credit score may not be available where we use alternative sources to assess their credit quality and predict behavior. The following table provides the most recent VantageScore credit scores, or equivalent, available for our revolving credit card and commercial credit product customers at June 30, 2025, December 31, 2024 and June 30, 2024, respectively, as a percentage of each class of loan receivable. The table below excludes 0.3% of our total loan receivables balance for our credit cards and commercial credit products at each of June 30, 2025, December 31, 2024 and June 30, 2024, which represents those customer accounts for which a VantageScore credit score, or equivalent, is not available.

------

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **June 30, 2024** | **June 30, 2024** | **June 30, 2024** |
| | **651 or**<br>**higher** | **591 to**<br>**650** | **590 or**<br>**less** | **651 or**<br>**higher** | **591 to**<br>**650** | **590 or**<br>**less** | **651 or**<br>**higher** | **591 to**<br>**650** | **590 or**<br>**less** |
| Credit cards | 74% | 18% | 8% | 73% | 19% | 8% | 73% | 19% | 8% |
| Commercial credit products | 83% | 11% | 6% | 83% | 7% | 10% | 84% | 7% | 9% |

---

*Consumer Installment Loans*

Delinquency trends are the primary credit quality indicator for our consumer installment loans, which we use to monitor credit quality and risk within the portfolio. The tables below include information on our consumer installment loans by origination year.

*Consumer Installment Loans by Origination Year*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **By origination year** | **By origination year** | **By origination year** | **By origination year** | **By origination year** | **By origination year** | |
| *At June 30, 2025 ($ in millions)* | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Total** |
| Amortized cost basis | $1094 | $1950 | $1376 | $805 | $320 | $124 | $5669 |
| 30-89 days delinquent | $11 | $37 | $33 | $23 | $9 | $4 | $117 |
| 90 or more days delinquent | $2 | $9 | $7 | $5 | $2 | $1 | $26 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **By origination year** | **By origination year** | **By origination year** | **By origination year** | **By origination year** | **By origination year** | |
| *At December 31, 2024 ($ in millions)* | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior** | **Total** |
| Amortized cost basis | $2581 | $1761 | $1005 | $424 | $166 | $34 | $5971 |
| 30-89 days delinquent | $47 | $44 | $30 | $12 | $5 | $1 | $139 |
| 90 or more days delinquent | $13 | $13 | $9 | $3 | $1 | $— | $39 |

---

*Gross Charge-offs for Consumer Installment Loans by Origination Year*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **By origination year** | **By origination year** | **By origination year** | **By origination year** | **By origination year** | **By origination year** | |
| *For the six months ended ($ in millions)* | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Total** |
| June 30, 2025 | $1 | $71 | $66 | $44 | $14 | $6 | $202 |
| June 30, 2024 | $— | $5 | $97 | $59 | $24 | $12 | $197 |

---

***Loan Modifications to Borrowers Experiencing Financial Difficulty***

The following tables provides information on our loan modifications made to borrowers experiencing financial difficulty during the periods presented, which do not include loans that are classified as loan receivables held for sale:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *Three months ended June 30* | **2025** | **2025** | **2024** | **2024** |
| *($ in millions)* | **Amount** | **% of Total Class of Loan Receivables** | **Amount** | **% of Total Class of Loan Receivables** |
| Long-term modifications |  |  |  |  |
| &nbsp;&nbsp;Credit cards | $383 | 0.4% | $409 | 0.4% |
| &nbsp;&nbsp;Consumer installment loans |  | —% |  | —% |
| &nbsp;&nbsp;Commercial credit products | 2 | 0.1% | 2 | 0.1% |
| Short-term modifications |  |  |  |  |
| &nbsp;&nbsp;Credit cards | 206 | 0.2% | 226 | 0.2% |
| &nbsp;&nbsp;Consumer installment loans |  | —% |  | —% |
| &nbsp;&nbsp;Commercial credit products |  | —% | 1 | —% |
| **Total** | $591 | 0.6% | $638 | 0.6% |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| *Six months ended June 30* | **2025** | **2025** | **2024** | **2024** |
| *($ in millions)* | **Amount**<sup>(a)</sup> | **% of Total Class of Loan Receivables** | **Amount** | **% of Total Class of Loan Receivables** |
| Long-term modifications |  |  |  |  |
| &nbsp;&nbsp;Credit cards | $822 | 0.9% | $880 | 0.9% |
| &nbsp;&nbsp;Consumer installment loans |  | —% |  | —% |
| &nbsp;&nbsp;Commercial credit products | 5 | 0.3% | 4 | 0.2% |
| Short-term modifications |  |  |  |  |
| &nbsp;&nbsp;Credit cards | 461 | 0.5% | 473 | 0.5% |
| &nbsp;&nbsp;Consumer installment loans |  | —% |  | —% |
| &nbsp;&nbsp;Commercial credit products | 1 | —% | 1 | —% |
| **Total** | $1289 | 1.3% | $1358 | 1.3% |

---

_______________________

(a)Represents balance at enrollment date. Long-term and short-term loan modifications made to borrowers for the six months ended June 30, 2025 had amortized cost balances at June 30, 2025 of $732 million and $124 million, respectively.

***Financial Effects of Loan Modifications to Borrowers Experiencing Financial Difficulty***

As part of our loan modifications to borrowers experiencing financial difficulty, we may provide multiple concessions to minimize our economic loss and improve long-term loan performance and collectability. For long-term modifications made in the three and six months ended June 30, 2025 and 2024, the financial effect of these modifications reduced the weighted-average interest rates by 97% for all periods presented. For short-term modifications made in the three months ended June 30, 2025 and 2024, unpaid balances of $13 million and $15 million, respectively, were forgiven related to borrowers who successfully exited the program. For short-term modifications made in the six months ended June 30, 2025 and 2024, unpaid balances of $118 million and $114 million, respectively, were forgiven related to borrowers who successfully exited the program. Additionally, beginning in late 2024, for borrowers that newly enroll in our short-term loan modification programs, we no longer charge interest and penalty fees during the term of the program and also typically waive accrued and unpaid interest and fees at the time of enrollment.

***Performance of Loans Modified to Borrowers Experiencing Financial Difficulty***

The following tables provide information on the performance of loans modified to borrowers experiencing financial difficulty which have been modified within the previous 12 months from the applicable balance sheet date and remained in a modification program at June 30, 2025 and 2024, respectively:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Amortized cost basis** | **Amortized cost basis** | **Amortized cost basis** | **Amortized cost basis** |
| *At June 30, 2025 ($ in millions)* | **Current** | **30-89 days delinquent** | **90 or more days delinquent** | **Total past due**<sup>(a)</sup> |
| Long-term modifications |  |  |  |  |
| &nbsp;&nbsp;Credit cards | $997 | $148 | $117 | $265 |
| &nbsp;&nbsp;Consumer installment loans |  |  |  |  |
| &nbsp;&nbsp;Commercial credit products | 4 | 1 | 1 | 2 |
| Short-term modifications |  |  |  |  |
| &nbsp;&nbsp;Credit cards | 56 | 30 | 38 | 68 |
| &nbsp;&nbsp;Consumer installment loans |  |  |  |  |
| &nbsp;&nbsp;Commercial credit products |  |  |  |  |
| Total delinquent modified loans | $1057 | $179 | $156 | $335 |
| Percentage of total loan receivables | 1.1% | 0.2% | 0.2% | 0.3% |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Amortized cost basis** | **Amortized cost basis** | **Amortized cost basis** | **Amortized cost basis** |
| *At June 30, 2024 ($ in millions)* | **Current** | **30-89 days delinquent** | **90 or more days delinquent** | **Total past due**<sup>(a)</sup> |
| Long-term modifications |  |  |  |  |
| &nbsp;&nbsp;Credit cards | $993 | $157 | $133 | $290 |
| &nbsp;&nbsp;Consumer installment loans |  |  |  |  |
| &nbsp;&nbsp;Commercial credit products | 3 | 1 | 1 | 2 |
| Short-term modifications |  |  |  |  |
| &nbsp;&nbsp;Credit cards | 67 | 36 | 45 | 81 |
| &nbsp;&nbsp;Consumer installment loans |  |  |  |  |
| &nbsp;&nbsp;Commercial credit products |  |  |  |  |
| Total delinquent modified loans | $1063 | $194 | $179 | $373 |
| Percentage of total loan receivables | 1.0% | 0.2% | 0.2% | 0.4% |

---

___________________

(a)&nbsp;&nbsp;&nbsp;&nbsp;Once a loan has been modified, it only returns to current status if the borrower pays the total minimum payment due or if the loan is re-aged after three consecutive monthly program payments are received post the modification date.

***Payment Defaults***

The following tables present the type, number and amount of loans to borrowers experiencing financial difficulty that enrolled in a long-term modification program within the previous 12 months from the applicable balance sheet date, and experienced a payment default and charged-off during the period presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *Three months ended June 30* | **2025** | **2025** | **2024** | **2024** |
| *($ in millions, accounts in thousands)* | **Accounts defaulted** | **Loans defaulted** | **Accounts defaulted** | **Loans defaulted** |
| Credit cards | 36 | $103 | 34 | $96 |
| Consumer installment loans |  |  |  |  |
| Commercial credit products |  | 1 | 1 | 1 |
| **Total** | 36 | $104 | 35 | $97 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| *Six months ended June 30* | **2025** | **2025** | **2024** | **2024** |
| *($ in millions, accounts in thousands)* | **Accounts defaulted** | **Loans defaulted** | **Accounts defaulted** | **Loans defaulted** |
| Credit cards | 67 | $190 | 81 | $214 |
| Consumer installment loans |  |  |  |  |
| Commercial credit products |  | 1 | 1 | 2 |
| **Total** | 67 | $191 | 82 | $216 |

---

Of the loans modified to borrowers experiencing financial difficulty that enrolled in a short-term modification program within the previous 12 months from the applicable balance sheet date, 63% and 56% had fully completed all required payments and successfully exited the program during the six months ended June 30, 2025 and 2024, respectively.

***Unfunded Lending Commitments*** 

We manage the potential risk in credit commitments by limiting the total amount of credit, both by individual customer and in total, by monitoring the size and maturity of our portfolios and by applying a consistent underwriting approach for all of our credit products. Unused credit card lines available to our customers totaled approximately $435 billion and $433 billion at June 30, 2025 and December 31, 2024, respectively. While these amounts represented the total available unused credit card lines, we have not experienced and do not anticipate that all of our customers will access their entire available line at any given point in time.

------

***Interest Income by Product***

The following table provides additional information about our interest and fees on loans, including merchant discounts, from our loan receivables, including held for sale:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Credit cards<sup>(a)</sup> | $5076 | $5013 | $10131 | $10109 |
| Consumer installment loans | 207 | 243 | 418 | 392 |
| Commercial credit products | 43 | 43 | 88 | 88 |
| Other | 2 | 2 | 3 | 5 |
| **Total**<sup>(b)</sup> | $5328 | $5301 | $10640 | $10594 |

---

_______________________

(a)Interest income on credit cards that was reversed related to accrued interest receivables written off was $578 million and $595 million for the three months ended June 30, 2025 and 2024, respectively, and $1.2 billion for both the six months ended June 30, 2025 and 2024, respectively.

(b)Deferred merchant discounts to be recognized in interest income at both June 30, 2025 and December 31, 2024, were $1.7 billion and $1.8 billion, respectively, which are included in Accrued expenses and other liabilities in our Condensed Consolidated Statements of Financial Position.

------

**NOTE 6.&nbsp;&nbsp;&nbsp;&nbsp;VARIABLE INTEREST ENTITIES**

We use VIEs to securitize loan receivables and arrange public and private asset-backed financing in the ordinary course of business through Synchrony Card Issuance Trust, as well as private asset-backed financing through Synchrony Credit Card Master Note Trust and Synchrony Sales Finance Master Trust. Investors in these entities only have recourse to the assets owned by the entity and not to our general credit. We do not have implicit support arrangements with any VIE and we did not provide non-contractual support for previously transferred loan receivables to any of these VIEs in the three and six months ended June 30, 2025 and 2024. Our VIEs are able to accept new loan receivables and arrange new asset-backed financings, consistent with the requirements and limitations on such activities placed on the VIE by existing investors. Once an account has been designated to a VIE, the contractual arrangements we have require all existing and future loan receivables originated under such account to be transferred to the VIE. The amount of loan receivables held by our VIEs in excess of the minimum amount required under the asset-backed financing arrangements with investors may be removed by us under removal of accounts provisions. All loan receivables held by a VIE are subject to claims of third-party investors.

The loan receivables in these entities have risks and characteristics similar to our other loan receivables and were underwritten to the same standard. Accordingly, the performance of these assets has been similar to our other comparable loan receivables, and the blended performance of the pools of receivables in these entities reflects the eligibility criteria that we apply to determine which receivables are selected for transfer. Contractually, the cash flows from these loan receivables must first be used to pay third-party debt holders, as well as other expenses of the entity. Excess cash flows, if any, are available to us. The creditors of these entities have no claim on our other assets.

The table below summarizes the assets and liabilities of our consolidated securitization VIEs described above:

---

| | | |
|:---|:---|:---|
| *($ in millions)* | **June 30, 2025** | **December 31, 2024** |
| **Assets** |  |  |
| Loan receivables, net<sup>(a)</sup> | $19346 | $19439 |
| Other assets<sup>(b)</sup> | 727 | 44 |
| **Total** | $20073 | $19483 |
| **Liabilities** |  |  |
| Borrowings | $8340 | $7842 |
| Other liabilities | 28 | 27 |
| **Total** | $8368 | $7869 |

---

_______________________

(a)&nbsp;&nbsp;&nbsp;&nbsp;Includes $1.9 billion and $1.9 billion of related allowance for credit losses resulting in gross restricted loan receivables of $21.2 billion and $21.3 billion at June 30, 2025 and December 31, 2024, respectively.

(b)&nbsp;&nbsp;&nbsp;&nbsp;Includes $720 million and $40 million of segregated funds held by the VIEs at June 30, 2025 and December 31, 2024, respectively, which are classified as restricted cash and equivalents and included as a component of Other assets in our Condensed Consolidated Statements of Financial Position.

The balances presented above are net of intercompany balances and transactions that are eliminated in our condensed consolidated financial statements.

We provide servicing for all of our consolidated VIEs. Collections are required to be placed into segregated accounts owned by each VIE in amounts that meet contractually specified minimum levels. These segregated funds are invested in cash and cash equivalents and are restricted as to their use, principally to pay maturing principal and interest on debt and the related servicing fees. Collections above these minimum levels are remitted to us on a daily basis.

Income (principally, interest and fees on loans) earned by our consolidated VIEs was $1.0 billion for both the three months ended June 30, 2025 and 2024. Related expenses consisted primarily of provision for credit losses of $260 million and $257 million for the three months ended June 30, 2025 and 2024, respectively, and interest expense of $104 million and $110 million for the three months ended June 30, 2025 and 2024, respectively.

------

Income (principally, interest and fees on loans) earned by our consolidated VIEs was $2.1 billion and $2.0 billion for the six months ended June 30, 2025 and 2024, respectively. Related expenses consisted primarily of provision for credit losses of $462 million and $422 million for the six months ended June 30, 2025 and 2024, respectively, and interest expense of $208 million and $215 million for the six months ended June 30, 2025 and 2024, respectively.

These amounts do not include intercompany transactions, principally fees and interest, which are eliminated in our condensed consolidated financial statements.

***Non-consolidated VIEs***

As part of our community reinvestment initiatives, we invest in funds that invest in affordable housing properties and receive affordable housing tax credits for these investments. We account for these investments using the proportional amortization method, where the costs of the investment are amortized in proportion to the income tax credits and other income tax benefits received. These investments are included in Other assets within our Condensed Consolidated Statements of Financial Position totaled $858 million and $776 million at June 30, 2025 and December 31, 2024, respectively, and represent our total exposure for these entities.

For the three months ended June 30, 2025 and 2024, provision for income taxes included amortization expense of $46 million and $24 million, respectively, and tax credits and other tax benefits of $55 million and $28 million, respectively, associated with investments in affordable housing properties. For the six months ended June 30, 2025 and 2024, provision for income taxes included amortization expense of $73 million and $47 million, respectively, and tax credits and other tax benefits of $88 million and $56 million, respectively, associated with investments in affordable housing properties.

Our other investments in non-consolidated VIEs, totaled $285 million and $274 million at June 30, 2025 and December 31, 2024, respectively, are included in Other assets within our Condensed Consolidated Statements of Financial Position. At June 30, 2025, the Company also had investment commitments of $183 million related to these investments.

**NOTE 7.&nbsp;&nbsp;&nbsp;&nbsp;INTANGIBLE ASSETS**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| *($ in millions)* | **Gross carrying amount** | **Accumulated amortization** | **Net** | **Gross carrying amount** | **Accumulated amortization** | **Net** |
| Capitalized software | $2541 | $(1736) | $805 | $2361 | $(1569) | $792 |
| Other | 194 | (137) | 57 | 195 | (133) | 62 |
| **Total** | $2735 | $(1873) | $862 | $2556 | $(1702) | $854 |

---

During the six months ended June 30, 2025, we recorded additions to intangible assets subject to amortization of $182 million, primarily related to capitalized software expenditures.

Amortization expense was $87 million and $80 million for the three months ended June 30, 2025 and 2024, respectively, and $173 million and $160 million for the six months ended June 30, 2025 and 2024, respectively, and is included as a component of Other expense in our Condensed Consolidated Statements of Earnings.

------

**NOTE 8.&nbsp;&nbsp;&nbsp;&nbsp;DEPOSITS**

***Deposits***

---

| | | |
|:---|:---|:---|
| *($ in millions)* | **June 30, 2025** | **December 31, 2024** |
| Interest-bearing deposits: |  |  |
| &nbsp;&nbsp;Money market and other demand deposits | $2757 | $2264 |
| &nbsp;&nbsp;Savings | 30964 | 28605 |
| &nbsp;&nbsp;Certificates of deposit |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Direct | 39596 | 41055 |
| &nbsp;&nbsp;&nbsp;&nbsp;Brokered | 4962 | 5891 |
| &nbsp;&nbsp;Brokered sweep accounts | 3578 | 3849 |
| Total interest-bearing deposits | 81857 | 81664 |
| Total non-interest-bearing deposits | 405 | 398 |
| **Total deposits** | $82262 | $82062 |

---

***Certificates of Deposit***

At June 30, 2025, our certificates of deposit maturing for the remainder of 2025 and over the next four years and thereafter were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| *($ in millions)* | **2025** | **2026** | **2027** | **2028** | **2029** | **Thereafter** |
| Certificates of deposit | $14622 | $22011 | $3651 | $1939 | $1178 | $1157 |

---

At June 30, 2025 and December 31, 2024, direct certificates of deposit of $11.1 billion and $11.2 billion, respectively, were of denominations at or exceeding applicable FDIC insurance limits, which are generally $250,000 per depositor for each account ownership category. These amounts include partially insured certificates of deposit. At June 30, 2025 and December 31, 2024, the portion of these direct certificates of deposit estimated to be uninsured was $3.8 billion and $3.7 billion, respectively. Brokered certificates of deposit are assumed to be individual deposit balances within applicable FDIC insurance limits.

***Brokered Sweep Deposits***

Our broker network deposit sweeps are procured through a program arranger who channels brokerage account deposits to us. Unless extended, the contracts associated with these broker network deposit sweeps will terminate between 2025 and 2029.

------

**NOTE 9.&nbsp;&nbsp;&nbsp;&nbsp;BORROWINGS**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **December 31, 2024** |
| *($ in millions)* | **Maturity date** | **Interest Rate** | **Weighted average interest rate** | **Outstanding Amount**<sup>(a)(b)</sup> | **Outstanding Amount**<sup>(a)(b)</sup> |
| **Borrowings of consolidated securitization entities:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed securitized borrowings | 2025 - 2028 | 3.86% - 5.74% | 4.95% | $5415 | $4917 |
| &nbsp;&nbsp;&nbsp;Floating securitized borrowings | 2026 - 2028 | 5.00% - 5.37% | 5.13% | 2925 | 2925 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total borrowings of consolidated securitization entities |  |  | 5.02% | 8340 | 7842 |
| **Senior unsecured notes:** |  |  |  |  |  |
| *Synchrony Financial senior unsecured notes:* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed senior unsecured notes | 2025 - 2031 | 2.88% - 5.15% | 4.05% | 3889 | 4637 |
| &nbsp;&nbsp;Fixed to floating senior unsecured notes<sup>(c)</sup> | 2030 - 2031 | 5.45% - 5.94% | 5.68% | 1540 | 745 |
| *Synchrony Bank senior unsecured notes:* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed senior unsecured notes | 2025 - 2027 | 5.40% - 5.63% | 5.49% | 1498 | 1497 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total senior unsecured notes |  |  | 4.73% | 6927 | 6879 |
| **Subordinated unsecured notes:** |  |  |  |  |  |
| *Synchrony Financial subordinated unsecured notes:* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed subordinated unsecured notes | 2033 | 7.25% | 7.25% | 742 | 741 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total senior and subordinated unsecured notes |  |  | 4.97% | 7669 | 7620 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total borrowings** |  |  |  | $16009 | $15462 |

---

___________________

(a)Includes unamortized debt premiums, discounts and issuance costs.

(b)The Company may redeem certain borrowings prior to their original contractual maturity dates in accordance with the optional redemption provision specified in the respective instruments.

(c)Includes $800 million principal amount issued in March 2025, interest rate fixed through March 6, 2030; resets March 7, 2030 to floating rate based on compounded Secured Overnight Financing Rate ("SOFR") plus 168 basis points.

***Debt Maturities***

The following table summarizes the maturities of the principal amount of our borrowings of consolidated securitization entities and senior and subordinated unsecured notes for the remainder of 2025 and over the next four years and thereafter:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| *($ in millions)* | **2025**<sup>(a)</sup> | **2026** | **2027** | **2028** | **2029** | **Thereafter** |
| Borrowings | $2575 | $3800 | $4200 | $1775 | $650 | $3050 |

---

___________________

(a)Includes $1.0 billion of fixed senior unsecured notes issued by Synchrony Financial and $675 million of fixed securitized borrowings which matured and were repaid in July 2025.

***Additional Sources of Liquidity***

We have undrawn committed and uncommitted capacity under certain credit facilities, primarily from private lenders under our securitization programs, subject to customary borrowing conditions, and also have access to the Federal Reserve discount window. At both June 30, 2025 and December 31, 2024, we had:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an aggregate of $2.6 billion of undrawn capacity under our securitization financings, of which $2.1 billion was committed and $450 million was uncommitted,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an aggregate of $500 million of undrawn committed capacity under our unsecured revolving credit facility with private lenders, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an aggregate of $10.8 billion and $11.5 billion, respectively, of available borrowing capacity through the Federal Reserve discount window based on the amount and type of assets pledged.

------

**NOTE 10.&nbsp;&nbsp;&nbsp;&nbsp;FAIR VALUE MEASUREMENTS**

For a description of how we estimate fair value, see Note 2. *Basis of Presentation and Summary of Significant Accounting Policies* in our 2024 annual consolidated financial statements within our 2024 Form 10-K. The following tables present our assets and liabilities measured at fair value on a recurring basis.

***Recurring Fair Value Measurements***

---

| | | | | |
|:---|:---|:---|:---|:---|
| *At June 30, 2025 ($ in millions)* | **Level 1** | **Level 2** | **Level 3** | **Total**<sup>(a)</sup> |
| **Assets** |  |  |  |  |
| Debt securities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. government and federal agency | $— | $1805 | $— | $1805 |
| &nbsp;&nbsp;&nbsp;&nbsp;State and municipal |  |  | 26 | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;Residential mortgage-backed |  | 283 |  | 283 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset-backed |  | 782 |  | 782 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other |  |  | 9 | 9 |
| Other<sup>(b)</sup> | 14 |  | 3 | 17 |
| **Total** | $14 | $2870 | $38 | $2922 |
| **Liabilities** |  |  |  |  |
| Other<sup>(c)</sup> | $— | $— | $1 | $1 |
| **Total** | $— | $— | $1 | $1 |
| *At December 31, 2024 ($ in millions)* | **Level 1** | **Level 2** | **Level 3** | **Total**<sup>(a)</sup> |
| **Assets** |  |  |  |  |
| Debt securities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. government and federal agency | $— | $1844 | $— | $1844 |
| &nbsp;&nbsp;&nbsp;&nbsp;State and municipal |  |  | 16 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;Residential mortgage-backed |  | 289 |  | 289 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset-backed |  | 922 |  | 922 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other |  |  | 8 | 8 |
| Other<sup>(b)</sup> | 14 |  | 6 | 20 |
| **Total** | $14 | $3055 | $30 | $3099 |
| **Liabilities** |  |  |  |  |
| Other<sup>(c)</sup> | $— | $— | $11 | $11 |
| **Total** | $— | $— | $11 | $11 |

---

_______________________

(a)&nbsp;&nbsp;&nbsp;&nbsp;For the six months ended June 30, 2025 and 2024, there were no fair value measurements transferred between levels and changes in our Level 3 assets and liabilities were not material.

(b)&nbsp;&nbsp;&nbsp;&nbsp;Other is primarily comprised of equity investments measured at fair value, which are included in Other assets in our Condensed Consolidated Statements of Financial Position, as well as certain financial assets for which we have elected the fair value option which are included in Loan receivables in our Condensed Consolidated Statements of Financial Position.

(c)&nbsp;&nbsp;&nbsp;&nbsp;Other includes certain financial liabilities for which we have elected the fair value option. These liabilities are included in Accrued expenses and other liabilities in our Condensed Consolidated Statements of Financial Position.

***Level 3 Fair Value Measurements***

Our Level 3 recurring fair value measurements primarily relate to state and municipal and corporate debt instruments, which are valued using non-binding broker quotes or other third-party sources, and financial assets and liabilities for which we have elected the fair value option. See Note 2. *Basis of Presentation and Summary of Significant Accounting Policies* in our 2024 annual consolidated financial statements within our 2024 Form 10-K for a description of our process to evaluate third-party pricing servicers. Our state and municipal debt securities are classified as available-for-sale with changes in fair value included in Accumulated other comprehensive income.

------

***Financial Assets and Financial Liabilities Carried at Other Than Fair Value***

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Carrying** | **Corresponding fair value amount** | **Corresponding fair value amount** | **Corresponding fair value amount** | **Corresponding fair value amount** |
| *At June 30, 2025 ($ in millions)* | **value** | **Total** | **Level 1** | **Level 2** | **Level 3** |
| **Financial Assets** |  |  |  |  |  |
| Financial assets for which carrying values equal or approximate fair value: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and equivalents<sup>(a)</sup> | $19457 | $19457 | $18960 | $497 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets<sup>(a)(b)</sup> | $722 | $722 | $722 | $— | $— |
| Financial assets carried at other than fair value: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loan receivables, net<sup>(c)</sup> | $89400 | $102983 | $— | $— | $102983 |
| **Financial Liabilities**<sup>(d)</sup>  |  |  |  |  |  |
| Financial liabilities carried at other than fair value: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deposits<sup>(e)</sup> | $82262 | $82372 | $— | $82372 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowings of consolidated securitization entities | $8340 | $8395 | $— | $5478 | $2917 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior and subordinated unsecured notes | $7669 | $7659 | $— | $7659 | $— |
|  | **Carrying** | **Corresponding fair value amount** | **Corresponding fair value amount** | **Corresponding fair value amount** | **Corresponding fair value amount** |
| *At December 31, 2024 ($ in millions)* | **value** | **Total** | **Level 1** | **Level 2** | **Level 3** |
| **Financial Assets** |  |  |  |  |  |
| Financial assets for which carrying values equal or approximate fair value: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and equivalents<sup>(a)</sup> | $14711 | $14711 | $14711 | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets<sup>(a)(b)</sup> | $44 | $44 | $44 | $— | $— |
| Financial assets carried at other than fair value: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loan receivables, net<sup>(c)</sup> | $93785 | $106632 | $— | $— | $106632 |
| **Financial Liabilities**<sup>(d)</sup>  |  |  |  |  |  |
| Financial liabilities carried at other than fair value: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deposits<sup>(e)</sup> | $82062 | $82256 | $— | $82256 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowings of consolidated securitization entities | $7842 | $7871 | $— | $4950 | $2921 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior and subordinated unsecured notes | $7620 | $7502 | $— | $7502 | $— |

---

_______________________

(a)&nbsp;&nbsp;&nbsp;&nbsp;For cash and equivalents and restricted cash and equivalents, carrying value approximates fair value due to the liquid nature and short maturity of these instruments. Cash equivalent classified as Level 2 represent U.S. Government and Federal Agency debt securities with original maturities of three months or less or acquired within three months or less of their maturity.

(b)&nbsp;&nbsp;&nbsp;&nbsp;This balance relates to restricted cash and equivalents, which is included in Other assets. Excludes accrued interest receivables of $32 million and $25 million at June 30, 2025 and December 31, 2024, respectively, for which carrying value approximates fair value.

(c)&nbsp;&nbsp;&nbsp;&nbsp;Includes loan receivables held for sale and excludes financial assets for which we have elected the fair value option. Under certain retail partner program agreements, the expected sales proceeds in the event of a sale of their credit card portfolio may be limited to the amounts owed by our customers, which may be less than the fair value indicated above.

(d)Excludes accrued interest payable of $323 million and $339 million, included in Accrued expenses and other liabilities, in our Condensed Consolidated Statements of Financial Position at June 30, 2025 and December 31, 2024, respectively, for which carrying values approximate fair value.

(e)Includes demand deposits with no defined maturity.

------

***Equity Securities Without Readily Determinable Fair Values***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Six months ended** | **Six months ended** |
| *At or for the periods ended June 30* <br>*($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Carrying value<sup>(a)</sup> | $275 | $273 | $275 | $273 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upward adjustments<sup>(b)</sup> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Downward adjustments<sup>(b)</sup> |  | (2) |  | (2) |

---

_______________________

(a)&nbsp;&nbsp;&nbsp;&nbsp;Carrying value reflects cumulative purchases and sales in addition to upward and downward carrying value changes, and at December 31, 2024 was $270 million.

(b)&nbsp;&nbsp;&nbsp;&nbsp;Between January 1, 2018 and June 30, 2025, cumulative upward and downward carrying value adjustments for equity securities held at June 30, 2025 were $201 million and $(9) million, respectively.

**NOTE 11.&nbsp;&nbsp;&nbsp;&nbsp;REGULATORY AND CAPITAL ADEQUACY** 

As a savings and loan holding company and a financial holding company, we are subject to regulation, supervision and examination by the Federal Reserve Board and subject to the capital requirements as prescribed by Basel III capital rules and the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act. The Bank is a federally chartered savings association. As such, the Bank is subject to regulation, supervision and examination by the Office of the Comptroller of the Currency of the U.S. Treasury (the "OCC"), which is its primary regulator, and by the Consumer Financial Protection Bureau ("CFPB"). In addition, the Bank, as an insured depository institution, is supervised by the FDIC.

Failure to meet minimum capital requirements can initiate certain mandatory and, possibly, additional discretionary actions by regulators that, if undertaken, could limit our business activities and have a material adverse effect on our consolidated financial statements. Under capital adequacy guidelines, we must meet specific capital guidelines that involve quantitative measures of our assets, liabilities and certain off-balance-sheet items as calculated under regulatory accounting practices. The capital amounts and classifications are also subject to qualitative judgments by the regulators about components, risk weightings and other factors.

Quantitative measures established by regulation to ensure capital adequacy require us and the Bank to maintain minimum amounts and ratios (set forth in the tables below) of Total, Tier 1 and common equity Tier 1 capital (as defined in the regulations) to risk-weighted assets (as defined), and of Tier 1 capital to average assets (as defined).

For Synchrony Financial to be a well-capitalized savings and loan holding company, the Bank must be well-capitalized and Synchrony Financial must not be subject to any written agreement, order, capital directive, or prompt corrective action directive issued by the Federal Reserve Board to meet and maintain a specific capital level for any capital measure.

The Company elected to adopt the option provided by the interim final rule issued by joint federal bank regulatory agencies, which largely delayed the effects of CECL on its regulatory capital. The effects were phased-in over a three-year period through 2024 and were fully phased-in beginning in the first quarter of 2025. Under the interim final rule, the amount of adjustments to regulatory capital deferred until the phase-in period included both the initial impact of our adoption of CECL at January 1, 2020 and 25% of subsequent changes in our allowance for credit losses during the two-year period ended December 31, 2021, collectively the "CECL regulatory capital transition adjustment". At December 31, 2024, 25% of the CECL regulatory capital transition adjustment was deferred in our regulatory capital amounts and ratios.

At June 30, 2025 and December 31, 2024, Synchrony Financial met all applicable requirements to be deemed well-capitalized pursuant to Federal Reserve Board regulations. At June 30, 2025 and December 31, 2024, the Bank also met all applicable requirements to be deemed well-capitalized pursuant to OCC regulations and for purposes of the Federal Deposit Insurance Act. There are no conditions or events subsequent to June 30, 2025 that management believes have changed the Company's or the Bank's capital category.

------

The actual capital amounts, ratios and the applicable required minimums of the Company and the Bank are as follows:

***Synchrony Financial***

---

| | | | | |
|:---|:---|:---|:---|:---|
| *At June 30, 2025 ($ in millions)* | **Actual** | **Actual** | **Minimum for capital <br>adequacy purposes** | **Minimum for capital <br>adequacy purposes** |
|  | **Amount** | **Ratio**<sup>(a)</sup> | **Amount** | **Ratio**<sup>(b)</sup> |
| Total risk-based capital | $17153 | 16.9% | $8137 | 8.0% |
| Tier 1 risk-based capital | $15025 | 14.8% | $6103 | 6.0% |
| Tier 1 leverage | $15025 | 12.7% | $4741 | 4.0% |
| Common equity Tier 1 Capital | $13803 | 13.6% | $4577 | 4.5% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| *At December 31, 2024 ($ in millions)* | **Actual** | **Actual** | **Minimum for capital <br>adequacy purposes** | **Minimum for capital <br>adequacy purposes** |
|  | **Amount** | **Ratio**<sup>(a)</sup> | **Amount** | **Ratio**<sup>(b)</sup> |
| Total risk-based capital | $17407 | 16.5% | $8433 | 8.0% |
| Tier 1 risk-based capital | $15239 | 14.5% | $6325 | 6.0% |
| Tier 1 leverage | $15239 | 12.9% | $4717 | 4.0% |
| Common equity Tier 1 Capital | $14017 | 13.3% | $4744 | 4.5% |

---

***Synchrony Bank***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| *At June 30, 2025 ($ in millions)* | **Actual** | **Actual** | **Minimum for capital <br>adequacy purposes** | **Minimum for capital <br>adequacy purposes** | **Minimum to be well-capitalized under prompt corrective action provisions** | **Minimum to be well-capitalized under prompt corrective action provisions** |
|  | **Amount** | **Ratio**<sup>(a)</sup> | **Amount** | **Ratio**<sup>(b)</sup> | **Amount** | **Ratio** |
| Total risk-based capital | $15928 | 16.4% | $7758 | 8.0% | $9698 | 10.0% |
| Tier 1 risk-based capital | $13854 | 14.3% | $5819 | 6.0% | $7758 | 8.0% |
| Tier 1 leverage | $13854 | 12.3% | $4508 | 4.0% | $5635 | 5.0% |
| Common equity Tier 1 capital | $13854 | 14.3% | $4364 | 4.5% | $6303 | 6.5% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| *At December 31, 2024 ($ in millions)* | **Actual** | **Actual** | **Minimum for capital <br>adequacy purposes** | **Minimum for capital <br>adequacy purposes** | **Minimum to be well-capitalized under prompt corrective action provisions** | **Minimum to be well-capitalized under prompt corrective action provisions** |
|  | **Amount** | **Ratio**<sup>(a)</sup> | **Amount** | **Ratio**<sup>(b)</sup> | **Amount** | **Ratio** |
| Total risk-based capital | $15916 | 15.8% | $8037 | 8.0% | $10046 | 10.0% |
| Tier 1 risk-based capital | $13805 | 13.7% | $6027 | 6.0% | $8037 | 8.0% |
| Tier 1 leverage | $13805 | 12.4% | $4466 | 4.0% | $5582 | 5.0% |
| Common equity Tier 1 capital | $13805 | 13.7% | $4521 | 4.5% | $6530 | 6.5% |

---

_______________________

(a)Capital ratios are calculated based on the Basel III Standardized Approach rules. Capital amounts and ratios at December 31, 2024 in the above tables reflect the applicable CECL regulatory capital transition adjustment.

(b)At June 30, 2025 and December 31, 2024, Synchrony Financial and the Bank also must maintain a capital conservation buffer of common equity Tier 1 capital in excess of minimum risk-based capital ratios by at least 2.5 percentage points to avoid limits on capital distributions and certain discretionary bonus payments to executive officers and similar employees.

The Bank may pay dividends on its stock, with consent or non-objection from the OCC and the Federal Reserve Board, among other things, if its regulatory capital would not thereby be reduced below the applicable regulatory capital requirements.

------

**NOTE 12.&nbsp;&nbsp;&nbsp;&nbsp;EARNINGS PER SHARE**

Basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per common share reflects the assumed conversion of all dilutive securities, which are calculated using the treasury stock method.

The following table presents the calculation of basic and diluted earnings per common share:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ and shares in millions, except per share data)* | **2025** | **2024** | **2025** | **2024** |
| Net earnings | $967 | $643 | $1724 | $1936 |
| Preferred stock dividends | (21) | (19) | (42) | (30) |
| Net earnings available to common stockholders | $946 | $624 | $1682 | $1906 |
| Weighted average common shares outstanding, basic | 376.2 | 399.3 | 380.7 | 402.0 |
| Effect of dilutive securities | 2.9 | 3.3 | 3.5 | 3.4 |
| Weighted average common shares outstanding, dilutive | 379.1 | 402.6 | $384.2 | 405.4 |
| Earnings per basic common share | $2.51 | $1.56 | $4.42 | $4.74 |
| Earnings per diluted common share | $2.50 | $1.55 | $4.38 | $4.70 |

---

We have issued stock-based awards under the Synchrony Financial 2024 Long-Term Incentive Plan, along with prior incentive plans. Awards that were considered anti-dilutive and therefore were excluded from the computation of diluted earnings per common share were less than 1 million shares for all periods presented.

**NOTE 13.&nbsp;&nbsp;&nbsp;&nbsp;INCOME TAXES**

***Unrecognized Tax Benefits***

---

| | | |
|:---|:---|:---|
| *($ in millions)* | **June 30, 2025** | **December 31, 2024** |
| Unrecognized tax benefits, excluding related interest expense and penalties<sup>(a)</sup> | $225 | $207 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portion that, if recognized, would reduce tax expense and effective tax rate<sup>(b)</sup> | $178 | $163 |

---

____________________

(a)Interest and penalties related to unrecognized tax benefits were not material for all periods presented.

(b)Comprised of federal unrecognized tax benefits and state and local unrecognized tax benefits net of the effects of associated U.S. federal income taxes. Excludes amounts attributable to any related valuation allowances resulting from associated increases in deferred tax assets.

We establish a liability that represents the difference between a tax position taken (or expected to be taken) on an income tax return and the amount of taxes recognized in our financial statements. The liability associated with the unrecognized tax benefits is adjusted periodically when new information becomes available. The amount of unrecognized tax benefits that is reasonably possible to be resolved in the next twelve months is expected to be $33 million, of which $26 million, if recognized, would reduce the Company's tax expense and effective tax rate.

In the current year, the Company executed a Memorandum of Understanding with the IRS to participate voluntarily in the IRS Compliance Assurance Process ("CAP") program for the 2025 tax year, and thus the tax year is under IRS review. The IRS is also examining our 2024 tax year, and we expect the review will be completed in the current year. Additionally, we are under examination in various states going back to 2014.

We believe that there are no issues or claims that are likely to significantly impact our results of operations, financial position or cash flows. We further believe that we have made adequate provision for all income tax uncertainties that could result from such examinations.

------

**NOTE 14.&nbsp;&nbsp;&nbsp;&nbsp;SEGMENT REPORTING**

We conduct our operations through a single business segment, which derives interest and fee income earned on our credit products we offer to our customers.

There have not been any changes to the basis of segmentation or the measurement of performance as compared to the 2024 Form 10-K.

The following table presents segment information for the periods presented herein:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| *($ in millions)* | **2025** | **2024** | **2025** | **2024** |
| Interest and fees on loans | $5328 | $5301 | $10640 | $10594 |
| Interest on cash and debt securities | 258 | 281 | 496 | 556 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest income | 5586 | 5582 | 11136 | 11150 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest expense | 1065 | 1177 | 2151 | 2340 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net interest income | 4521 | 4405 | 8985 | 8810 |
| Retailer share arrangements | (992) | (810) | (1887) | (1574) |
| Reserve build (release) | (265) | 70 | (362) | 369 |
| Net charge-offs | 1411 | 1621 | 2999 | 3206 |
| Provision for credit losses | 1146 | 1691 | 2637 | 3575 |
| Other income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income | 118 | 117 | 267 | 205 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of business<sup>(a)</sup> |  |  |  | 1069 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other income | 118 | 117 | 267 | 1274 |
| Other expense: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee costs | 509 | 434 | 1015 | 930 |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional fees | 236 | 236 | 453 | 456 |
| &nbsp;&nbsp;&nbsp;&nbsp;Marketing and business development | 127 | 129 | 243 | 254 |
| &nbsp;&nbsp;&nbsp;&nbsp;Information processing | 215 | 207 | 434 | 393 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fraud-related operational losses | 34 | 50 | 75 | 100 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other segment items<sup>(b)</sup> | 124 | 121 | 268 | 250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense | 1245 | 1177 | 2488 | 2383 |
| Provision for income taxes | 289 | 201 | 516 | 616 |
| **Net earnings** | $967 | $643 | $1724 | $1936 |

---

**_____________**

(a)Includes $1.1 billion gain on sale recognized in the six months ended June 30, 2024 related to the sale of Pets Best. See Note 3. Acquisitions and Dispositions to our 2024 annual consolidated financial statements in our 2024 Form 10-K for additional information.

(b)Represents the total amount of other expenses included in net earnings, including postage and various other corporate overhead items such as facilities costs and telephone charges.

Our segment assets represent our total assets as presented on the Condensed Consolidated Statements of Financial Position.

------

**NOTE 15.&nbsp;&nbsp;&nbsp;&nbsp;LEGAL PROCEEDINGS AND REGULATORY MATTERS**

In the normal course of business, from time to time, we have been named as a defendant in various legal proceedings, including arbitrations, class actions and other litigation, arising in connection with our business activities. Certain of the legal actions include claims for substantial compensatory and/or punitive damages, or claims for indeterminate amounts of damages. We are also involved, from time to time, in reviews, investigations and proceedings (both formal and informal) by governmental agencies regarding our business (collectively, "regulatory matters"), which could subject us to significant fines, penalties, obligations to change our business practices or other requirements resulting in increased expenses, diminished income and damage to our reputation. We contest liability and/or the amount of damages as appropriate in each pending matter. In accordance with applicable accounting guidance, we establish an accrued liability for legal and regulatory matters when those matters present loss contingencies which are both probable and reasonably estimable.

Legal proceedings and regulatory matters are subject to many uncertain factors that generally cannot be predicted with assurance, and we may be exposed to losses in excess of any amounts accrued.

For some matters, we are able to determine that an estimated loss, while not probable, is reasonably possible. For other matters, including those that have not yet progressed through discovery and/or where important factual information and legal issues are unresolved, we are unable to make such an estimate. We currently estimate that the reasonably possible losses for legal proceedings and regulatory matters, whether in excess of a related accrued liability or where there is no accrued liability, and for which we are able to estimate a possible loss, are immaterial. This represents management's estimate of possible loss with respect to these matters and is based on currently available information. This estimate of possible loss does not represent our potential maximum loss exposure. The legal proceedings and regulatory matters underlying the estimate will change from time to time and actual results may vary significantly from current estimates.

Our estimate of reasonably possible losses involves significant judgment, given the varying stages of the proceedings, the existence of numerous yet to be resolved issues, the breadth of the claims (often spanning multiple years), unspecified damages and/or the novelty of the legal issues presented. Based on our current knowledge, we do not believe that we are a party to any pending legal proceeding or regulatory matters that would have a material adverse effect on our condensed consolidated financial condition or liquidity. However, in light of the uncertainties involved in such matters, the ultimate outcome of a particular matter could be material to our operating results for a particular period depending on, among other factors, the size of the loss or liability imposed and the level of our earnings for that period, and could adversely affect our business and reputation.

------

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Market risk refers to the risk that a change in the level of one or more market prices, rates, indices, correlations or other market factors will result in losses for a position or portfolio. We are exposed to market risk primarily from changes in interest rates.

We borrow money from a variety of depositors and institutions in order to provide loans to our customers. Changes in market interest rates cause our net interest income to increase or decrease, as some of our assets and liabilities carry interest rates that fluctuate with market benchmarks. The interest rate benchmark for our floating rate assets is generally the prime rate, and the interest rate benchmark for our floating rate liabilities is generally either the Secured Overnight Financing Rate ("SOFR"), U.S. Treasury bills, or the federal funds rate. The prime rate and the SOFR, U.S. Treasury bills or federal funds rate could reset at different times or could diverge, leading to mismatches in the interest rates on our floating rate assets and floating rate liabilities.

The following table presents the approximate net interest income impacts forecasted over the next twelve months from an immediate and parallel change in interest rates affecting all interest rate sensitive assets and liabilities at June 30, 2025.

---

| | |
|:---|:---|
| **Basis Point Change** | **At June 30, 2025** |
| *($ in millions)* |  |
| &nbsp;&nbsp;&nbsp;-100 basis points | $(164) |
| &nbsp;&nbsp;&nbsp;+100 basis points | $73 |

---

For a more detailed discussion of our exposure to market risk, refer to "*Management's Discussion and Analysis—Quantitative and Qualitative Disclosures about Market Risk*" in our 2024 Form 10-K.

**ITEM 4. CONTROLS AND PROCEDURES**

Under the direction of our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), and based on such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2025.

No change in internal control over financial reporting occurred during the fiscal quarter ended June 30, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II. OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

For a description of legal proceedings, see Note 15. *Legal Proceedings and Regulatory Matters* to our condensed consolidated financial statements in Part 1, Item 1 of this Quarterly Report on Form 10-Q.

**ITEM 1A. RISK FACTORS**

There have been no material changes to the risk factors included in our 2024 Form 10-K under the heading *"Risk Factors Relating to Our Business"* and *"Risk Factors Relating to Regulation".*

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

The table below sets forth information regarding purchases of our common stock primarily related to our share repurchase program that were made by us or on our behalf during the three months ended June 30, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| *($ in millions, except per share data)* | **Total Number of Shares Purchased**<sup>(a)</sup> | **Average Price Paid Per Share**<sup>(b)</sup> | **Total Number of Shares** <br>**Purchased as** <br>**Part of Publicly Announced Programs** | **Maximum Dollar Value of Shares That May Yet Be Purchased Under the Programs**<sup>(b)(c)</sup> |
| April 1 - 30, 2025 | 1963034 | $51.70 | 1909593 | $2401.3 |
| May 1 - 31, 2025 | 5260066 | 56.98 | 5258406 | 2101.7 |
| June 1 - 30, 2025 | 1654690 | 61.48 | 1654480 | 2000.0 |
| **Total** | 8877790 | $56.32 | 8822479 | $2000.0 |

---

_______________________

(a)Includes 53,441 shares, 1,660 shares and 210 shares withheld in January, February and March, respectively, to offset tax withholding obligations that occur upon the delivery of outstanding shares underlying performance stock awards, restricted stock awards or upon the exercise of stock options.

(b)Amounts exclude commission costs.

(c)In April 2025, the Company announced that the Board of Directors approved a new share repurchase program of up to $2.5 billion through June 30, 2026.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

None.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

------

**ITEM 5. OTHER INFORMATION**

**Rule 10b5-1 Trading Plans**

During the three months ended June 30, 2025, no directors or officers of the Company adopted, modified or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each such term is defined in item 408(a) of Regulation S-K.

------

**ITEM 6. EXHIBITS** 

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| <u>[3.1](https://www.sec.gov/ix?doc=/Archives/edgar/data/1601712/000160171224000218/syf-20240611.htm)</u> | <u>[Second Amended and Restated Certificate of Incorporation of Synchrony Financial (incorporated by reference to Exhibit 3.1 of Form 8-K filed by Synchrony Financial on June 13, 2024 (No. 001-36560))](https://www.sec.gov/ix?doc=/Archives/edgar/data/1601712/000160171224000218/syf-20240611.htm)</u> |
| <u>[3.2](https://www.sec.gov/Archives/edgar/data/1601712/000160171216000178/syfbylaws.htm)</u> | <u>[Amended and Restated Bylaws of Synchrony Financial (incorporated by reference to Exhibit 3.1 of Form 8-K filed by Synchrony Financial on November 1, 2016 (No. 001-36560))](https://www.sec.gov/Archives/edgar/data/1601712/000160171216000178/syfbylaws.htm)</u> |
| <u>[31(a)\*](ex-31a6302025.htm)</u> | <u>[Certification Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended](ex-31a6302025.htm)</u> |
| <u>[31(b)\*](ex-31b6302025.htm)</u> | <u>[Certification Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended](ex-31b6302025.htm)</u> |
| <u>[32\*](ex-326302025.htm)</u> | <u>[Certification Pursuant to 18 U.S.C. Section 1350](ex-326302025.htm)</u> |
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | XBRL Taxonomy Extension Schema Document |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, formatted in Inline XBRL (included as Exhibit 101) |

---

______________________

\*Filed electronically herewith.

------

**Signatures** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Synchrony Financial

(Registrant)

---

| | |
|:---|:---|
| July 23, 2025 | /s/ Brian J. Wenzel Sr. |
| Date | Brian J. Wenzel Sr.<br>Executive Vice President and Chief Financial Officer<br>(Duly Authorized Officer and Principal Financial Officer) |

---

## Ex-31.A

**Exhibit 31(a)** 

**Certification Pursuant to** 

**Rules 13a-14(a) or 15d-14(a) Under the Securities Exchange Act of 1934, as Amended** 

I, Brian D. Doubles, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Synchrony Financial;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: July 23, 2025

---

| |
|:---|
| /s/ Brian D. Doubles |
| Brian D. Doubles<br>Chief Executive Officer |

---

## Ex-31.B

**Exhibit 31(b)** 

**Certification Pursuant to** 

**Rules 13a-14(a) or 15d-14(a) Under the Securities Exchange Act of 1934, as Amended** 

I, Brian J. Wenzel Sr., certify that:

1. I have reviewed this quarterly report on Form 10-Q of Synchrony Financial;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: July 23, 2025

---

| |
|:---|
| /s/ Brian J. Wenzel Sr. |
| Brian J. Wenzel Sr.<br>Chief Financial Officer |

---

## Ex-32

**Exhibit 32** 

**Certification Pursuant to** 

**18 U.S.C. Section 1350** 

In connection with the Quarterly Report of Synchrony Financial (the "registrant") on Form 10-Q for the period ended June 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "report"), we, Brian D. Doubles, Chief Executive Officer, and Brian J. Wenzel Sr., Chief Financial Officer, of the registrant, certify, pursuant to 18 U.S.C. § 1350, that to our knowledge:

1. The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the registrant.

Date: July 23, 2025

---

| |
|:---|
| /s/ Brian D. Doubles |
| Brian D. Doubles<br>Chief Executive Officer |

---

---

| |
|:---|
| /s/ Brian J. Wenzel Sr. |
| Brian J. Wenzel Sr.<br>Chief Financial Officer |

---

<br>